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Nowadays more and more people concern about the healthcare-related natural 
products, especially the pharmacological properties of medicinal herbs and edible 
plants. Antitumor is one of the numerous pharmacological effects that have raised 
public interest. In this study, Wedelia thlobata was extracted and fractionated, and 
the antitumor activites of the fractions were investigated using in vitro and in vivo 
assays. 
After screening the antitumor activity of water extracts of four Compositae 
species, Wedelia thlobata was chosen for detailed investigation in this project. Hot 
water extraction, ethanol precipitation and further fractionation were performed. The 
ethanol supernatant (WT4) was fractionated by a macroporus resin column. Four 
fractions, WT4-1, WT4-2, WT4-3 and WT4-4, with decreasing polarity were 
collected. The most active fraction WT4-4 was further fractionated by silica gel 
'column. Then four fractions, WT4-4 A, WT4-4 B, WT4-4 C and WT4-4 D, with 
increasing polarity were collected. WT4-4 A was found to be the most effective 
fraction. A purified component (crystal) was collected from WT4-4 A and was 
J determined to be sesquiterpene lactone with the chemical structure C23H32O9 by 
i 
X-ray crystallography. 
The extracts, fractions and crystal were subjected to in vitro antitumor assay. 
WT 4-4 significantly inhibited the proliferation ofHL-60, K-562, SI80，HepG2 and 
MCF-7, with I C 5 0 of 4 ^ig/ml, 6.5 |ig/ml, 8 |ig/ml, 24 |Lig/ml and 36 |^g/ml 
respectively. WT 4-4 showed no significant toxicity against normal human liver cell 
line L-02 and normal monkey kidney cell line Vero up to 50 |ag/ml and 6.25 ^ig/ml 
respectively. I C 5 0 of the further purified WT4-4 A on proliferation of HL-60, K-562 
and SI80 was 3 |Lig/ml, 3.4 |ag/ml and 2.8 jag/ml respectively. The I C 5 0 of the 
sesquiterpene lactone on proliferation of HL-60 was 2.2 |ag/ml. DNA from WT4-4 
treated HL-60, K-562 and S-180 did not show DNA laddering pattern on DNA 
agarose gel electrophoresis. 
Since WT 4-4 could significantly inhibit the growth of S-180 cell line, in vivo 
antitumor assay using Sarcoma 180 tumor-bearing BALB/c mice was also carried out. 
After 10 consecutive days of intraperitoneal injection of WT4-4 at 3.2 mg/kg, there 
was 62.95% inhibition on tumor growth. WT4-4 did not have significant effect on 












WT4-4 A �B �C及D，極性由弱至強，而W T 4 - 4 A爲最有效部位’並於當中 
取得純品結晶°經X-射錢衍射檢測後其化學結構被測定爲C23H32O9，屬倍半 
轄烯內酯。 
於提取過程所得的各部位均進行體外抗癌測試，W T 4 - 4有效地抑制 
HL-60�K-562�S-180�HepG2及MCF-7等腫瘤細胞株之生長’其 IQg分別爲 
4 ^ig/ml�6.5 | i g / m l � 8 ^ig/ml�24 ^ig/ml 及 36 \ig/m\ ° WT4-4 於 50 ^ig/ml 對正常 
广 人類肝臟細胞(L-02)並無毒性’於6.25 ^ig/rnl或以下對正常猴賢細胞(Vero)並未 
y 產生毒性。而被更進一步純化的WT4-4 A比W T 4 - 4更能抑制H L - 6 0 �K - 5 6 2及 
iii 
S-180 之生長，其 ICsG分別爲 3 lag/ml�3.4 ^ig/ml 及 2.8 ^ig/ml ° 於 WT4-4 取得 
的純品結晶對HL-60之抗癌能力較WT4-4 A高一些，其ICso爲2.2 ^ig/ml °經 
WT4-4 一同體外培養三天的HL-60�K-562及S-180之DNA並沒有於DNA電 
泳中顯示DNA梯級式樣。 
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Recently, interest in medicinal value and clinical use of natural products has 
been in tremendous surge and many commercialized natural health-related products 
are widely accepted by the public. Actually, both 'whole plant' and ‘plant derived 
drug' are common in modern medicine, especially those plant derived medicine 
(Robbers et al, 1996). Among the bioactivities in natural products, antitumor is one 
of that have raised people's interest. Although there are now many drugs or 
radiotherapy for cancer treatment, the need for better and more variety of drugs for 
cancer patients is still desirable. It is because current chemotherapy or radiotherapy 
has many side effects such as loss of hair and body weight or development of 
resistance, although there are improvements (Jong and Donovick, 1989). So, 
J searching for new antitumor drug from a rich source, plants, is still in great needs. 
1 
Introduction 
Herbal therapy has a long history in China and India (Bedi and Shenefelt, 2002) 
and it is regaining the prominent position in many developing and developed 
countries nowadays (Li, 2000; Li, 2002). Moreover, plants have become a natural 
source for modern drug, as there are about 40% of modern pharmaceuticals coming 
from natural origin (Samuelsson, 1999). Examples of successful plant-derived 
antitumor drugs include camptothecin from Camptotheca acuminata and taxol from 
Taxus brevifolia (Lin et al., 2002). 
In searching bioactive components, Compositae being the largest flowering 
plant Family which comprises more then 23,000 known species is a big source 
(Bremer et al., 1994). Many Compositae plants are traditionally used as medicinal 
herbs and different bioactivities have been reported, for examples, some are used to 
treat infection and headaches (Smith, 1911), whereas others are found to have 
hepatoprotective activity (Lin et al., 1994) and antitumor activity (Kupchan and 
Bauerschmidt, 1971; Roussakis et al, 1984). Both in vitro and in vivo antitumor 
activities of Compositae species have been reported. For examples, the methanolic 
extract of Emilia sonchifolia has significant in vitro cytotoxic effect on DL, ECA and 
1 L-929 cancer c e l l lines with E C 5 0 at 1.5 mg/ml, 1 mg/ml and 15 |j.g/ml respectively. 
J It also significantly reduced DL solid tumor in vivo through oral administration 
2 
Introduction 
(Shylesh and Padikkala, 2000). Although there are no single standardized procedures 
to study in vivo antitumor effect, and there are different parameters used to illustrate 
the effect, for examples increased in life span and reduced in tumor size, the basic 
method is similar. Firstly, the selected tumor cell line was inoculated into the 
selected animal models for tumor formation. Secondly, the tumor-bearing animal 
models would receive the tested sample for several dosages and finally are sacrificed 
and the parameters used to illustrate the antiumor effect would be measured (Kaneda 
et al, 1997; Shylesh and Padikkala, 2000; Wang et ai, 2000). Even though the basic 
method is more or less the same, the period for each step and route of administration 
may be different. This is also the case for in vitro antitumor assay. 
When people concerns about antitumor effect of a natural product, they also are 
interested in mechanisms behind the drug effect. An antitumor drug may exert the 
effect through many pathways. Cell cycle control and apoptosis are two common 
means. For examples, taxol cause cell cycle arrestment in G2/M phase in cancer cells 
in order to block the cell division (Horwitz, 1992), and aqueous extract of Salvia 
miltiorrhiza induced apoptosis with DNA fragmentation in cancer cell line (Liu et al., 
2000). Cell cycle arrestment can be illustrated by flow cytometry using the sample 
J treated cancer cells (Soni et al., 2000; Towle et al, 2001) while DNA fragmentation, 
3 
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hallmark of apoptosis, can be illustrated by DNA gel electrophoresis of the DNA 
from sample treated cancer cells (Cotter and Martin, 1996; DeBlois et al., 2000). 
In this project, the antitumor activity of four Compositae species namely 
Dendranthema indicum, Dendranthema morifolium. Taraxacum mongolicum and 
Wedelia trilobata were screened using in vitro assay. Wedelia trilobata was chosen 
for further investigation because it's extracts had strong activity and it is easily 
available on campus. It belongs to the family Asteraceae and tribe Heliantheae, is 
introduced into Hong Kong from South America and now widely spread as 
decorative plant. 
Wedelia is a large genus, and compounds usually found in various Wedelia 
species include flavonoid, terpenoid and lactone (Bohlmann et al, 1984; Block et al, 
1998). Moreover, sesquiterpene lactones, which are also frequently found in 
Compositae, possess many biological activities (Maries et al, 1995). 
Folkloric use of Wedelia species can be found in many countries to treat 
swelling, headaches, fevers, infections and pathologies of the respiratory tract. Other 
than folkloric use, they were also reported to have hepatoprotective (Gopalakrishnan 
et a l , 1989), hypoglycaemic (Novaes et al, 2001), antimicrobial (Taddei and 
J Rosas-Romero, 1999), antifeedant and antifungal (Miles et al, 1990; Miles et al., 
4 
Introduction 
1993) activities. Wedelia trilobata has also traditionally been used to relief 
discomfort symptoms of colds and flu, hepatitis, indigestion, and infections (Roque 
et al, 1987; Miles et al., 1990; Lin et al, 1994). Although antitumor activity has 
been reported in several Compositae species (Shylesh and Padikkala, 2000; 
Chatterjee et al, 1999; Bedi and Shenefelt, 2002), bioactivity of Wedelia trilobata 
was seldom investigated. The antitumor and related bioactivity of Wedelia trilobata 
is deserved further investigation. 
In this thesis, the antitumor activity of different fractions and components 
isolated from Wedelia trilobata was investigated using both in vitro and in vivo 
assays. The in vitro cytotoxic effect on normal cell lines was investigated by MTT 
assay method, and the in vivo side effect was expressed as change in body weight in 
the sample treated tumor-bearing mice group as compared to untreated normal group. 
The effect of the active fraction on DNA of tumor cell lines was investigated by 







2.1 Medicinal Plants and Herbs 
The use of herbal therapy originated in China and India and has a history of 
thousands of years (Bedi and Shenefelt, 2002). In China, the first recorded use of 
medicinal plants dates back to 2800 BC and the legendary use was even earlier 
(Borchers et al, 1997). While in Indian, Ayurvedic medicine dates back to 3000 BC 
(Bedi and Shenefelt, 2002). The medical use of plants and herbs is still common 
nowadays. In 1999, the Chief Executive of Hong Kong Special Administrative 
Region of the People's Republic of China, Mr. Tong Chee Hwa, declared that he 
would like to put lots of efforts to develop Hong Kong as a world centre for 
Traditional Chinese Medicine (TCM) (Li, 2002). 
J Nowadays, people and mass media worldwide more and more concern the 
6 
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use of medicinal plants or herbs and natural health products, both for their 
pharmaceutical properties in health and cosmetic use. In China, Egypt, Indian, and 
other developing countries, people are still widely employing the medicinal plants as 
part of medical practice (Li, 2000). Moreover, eighty percent of the world's 
population is still using traditional medicine (Li, 2002), either due to the high cost of 
modern medical services, limited source of modem medicine or increasing concepts 
of health enhancement. 
Other than Asian countries, there are also explosive growth in the use of 
medicinal plants and related remedies over the past few decades in Western countries. 
Only in the United States, there is approximately 15 percent annual increase in the 
consumption of medicinal herbs (Marwick, 1995). A consumer survey for the year 
1996 reported that during the previous year, about one-third of all adult Americans 
were estimated to have used a herbal product and these people were estimated to 
spend about US$3.24 billion per year on herbs (Klepser and Klepser, 1999; Neldner, 
2000)： So, it is not surprising that, there has been a great interest in medicinal plants 
and herbs, and in both North America and Europe, natural products have become a 




2.1.1 Antitumor activities 
Cancer, being the third major cause of mortality, is the largest single cause of 
death in both men and women in the world, causing over 6 million deaths per year 
(Yang et al., 2000). Radiotherapy and chemotherapy being the major traditional 
cancer therapy, cause many adverse side effects, for example vomit and loss of hair. 
Many anticancer drugs have been developed and used clinically nowadays, however, 
development of resistance to anticancer drugs has been observed. Therefore, new 
safe drugs are in great needs. 
Plants and natural products, being the invaluable source of drug discovery, 
possessing various biological activities, for examples, antiviral (Vivian et al., 2001), 
antioxidant (VanderJagt et al, 2002) and anti-inflammatory (Motohiko et al., 2001), 
have been vastly searched and investigated. The antitumor activity is also of great 
interest. Some successful examples in discovering antitumor, cancer chemoprotective 
activities or antitumor drug derived from plants, are camptothecin, taxol, magnolol 
(Lin ei al, 2002) and resveratrol (Hsieh and Wu, 1999; Park et al., 2000). 
2.1.1.1 Successful examples - Camptothecin 
I 
J Compounds occurring in nature usually possess wide range of biological 
8 
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activities, and most of them are secondary metabolites. Camptothecin (CPT) is one 
of the most famous natural products derived from plants which possess antiutumor 
effects on a wide range of tumors, for examples, breast cancer, carcinoma of stomach, 
rectum, colon and bladder, and chronic leukaemia (Li, 2002). It is also clinically used 
in the United States. 
Camptothecin, being a promising new class of antitumor drugs over the last 
decade, was initially extracted from stembark of Camptotheca acuminata, Xi Shu, a 
native Chinese tree, and the chemical structure was identified by Wall et al. (1966). 
CPT is a pentacyclic indole alkaloid, with molecular weight of 348.111, and 
formula C20H16N2O4 with unique structure involving terminal closed a-hydroxy-6-
lactone in ring E (Wall and Wani, 1996). The lactone E-ring of CPT molecule is 
probably the site responsible for the antitumor activity (Keir et aL, 2001). 
However, natural camptothecins share a common property (Fig. 2.1). The 
a-hydroxy lactone ring is intrinsic instable and undergoes hydrolysis in alkaline pH, 
pH>8.0, for example in physiological conditions, to give the open-ring, water soluble 
carboxylate form with decreased in vivo and in vitro antitumor activity. But in acidic 
medium, pH<5, the carboxylate form undergoes relactonization to become the more 
I 
J active lactone form CPT, which is extremely water-insoluble but soluble in 
9 
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dimethylsulfoxide (DMSO) (Wall et al., 1966; Ahmed et al, 1998; Adams et al.’ 
2000; Oguma, 2001). Since naturally occur CPT is highly labile in nature, present in 
small amounts and water insoluble, in the past few decades, a lot of efforts have been 
applied to produce more stable CPT analogues with equal or higher antitumor 
activity and higher solubility, 
CPT and its analogues for examples, irinotecan (CPT-11), topotecan (TPT), 
10-hydroxycamptothecin (HCPT) and 7-t-butoxyiminomethylcamptothecin 
(ST1481), are reported to have good antitumor effect on wide range of tumors. 
CPT-11 and TPT demonstrated significant antitumor effect in clinical trials 
(Adams et al‘, 2000). CPT-11 is proved and clinically available to treat colorectal 
cancer while TPT to treat ovarian and small-cell lung cancers (Keir et al, 2001; 
Oguma, 2001). In Japan, CPT-11 became available since 1994 while in the United 
States, it is used to treat advanced colorectal adenocarcinoma (Okuno et al,, 2000). 
CPT-11 is also reported to be effective in human breast cancer in vitro and in vivo, 
through'apoptotic pathway (Zhang, 1997; Liu and Zhang, 1998). 
HCPT showed in vivo and in vitro antitumor effects against human breast 
,cancer cell lines MCF-7 and MDA-MB-468 (Liu and Zhang, 1998) while lipophilic 
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overcome the breast cancer resistance protein (BCRP) - associated resistance in 
colon carcinoma cell line HT29/MIT in vitro and in vivo (Perego et al, 2001). 
CPT and its analogues are well known to be effective through the inhibition 
of nuclear enzyme topoisomerase I (T-I), an enzyme responsible for different cellular 
DNA transaction such as replication, transcription, and recombination (Hsiang et al, 
1985). Moreover, the antitumor activity of CPT was maximized in the S-phase of the 
cell cycle and recognized as S phase-specific agents (Del Bino et al., 1991). 
Although the active lactone E-ring of CPT is labile in physiological pH, the reaction 
is reversible and many solid tumors produce lactic acid in anaerobic glycolysis that 
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Figure 2.1 Structure of lactone and carboxylate form of camptothecin (Adopted 
from Adams, 2000). 






2.1.1.2 Successful examples 一 Taxol 
In the last decade, taxol, a diterpenoid plant product, is one of the most famous 
antitumor agents introduced in clinical oncology (Svojanovsky et al, 1999). Taxol, 
same as CPT, is a secondary metabolite in plant. This antitumor compound was 
discovered and first isolated as an active constituent from the bark of Taxus brevifolia 
(Pacific yew) in Washington state in 1971 (Wani et al, 1971). T. brevifolia is a slow 
growing tree mainly found in the coastal areas of Washington state of the United 
States (Wall and Wani, 1996). 
The chemical structure of taxol is very complex (Fig. 2.2), consisting of a 
taxane ring system linked to a unique four-membered oxetane ring, which does not 
occur in any other natural taxanes, and an ester side chain (Wani et al, 1971). The 
side chain of taxol is probably responsible for it's antitumor effect because analogues 
of taxol without the side chain are not cytotoxic (Horwitz，1992). 
Taxol was reported to exhibit profound antineoplastic effects against a wide 
range of human tumors，for examples, breast, ovarian, head and neck, small cell and 
non-small-cell lung cancers and metastatic melanomas (Rowinsky et al, 1992; Kohn 
打 aL, 1994; Rowinsky and Donehower, 1995). According to its activity in human 
J clinical trials, the U.S. Food and Drug Administration (FAD) has approved taxol for 
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use against ovarian cancer (Rao et al, 1995). 
When deducing the antitumor mechanism of taxol, it is very logical to suggest 
that the unique diterpenoid structure would relate to a novel mechanism. In 1970s the 
mechanism of taxol antitumor effect was actually described as unique among plant 
alkaloids (Svojanovsky et al., 1999). The cytotoxicity effect of taxol is to induce the 
formation of highly stable microtubules, which are vital to mitosis. Since these 
microtubules are so stable, they resist depolymerization to tubulin, cause cells 
arrestment in the late G2/M phase of cell cycle, block the mitotic stage and so inhibit 
cell division (Horwitz, 1992). 
J 
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Figure 2.2 Structure of taxol (Adopted from Parekh and Simpkins, 1997). 
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2.2 Compositae and its Traditional Functions 
Compositae (Asteraceae) consists of herbs, shrubs, or trees (although less 
common), and is the largest family of flowering plants. They share the same 
characteristic of having reduced flowers and organized into an involucrate 
pseudanthium in the form of a head or capitulum. Many Compositae flowers are very 
attractive and beautiful, so people used them as ornamental plants around the world. 
According to a comparatively recent subfamilial classification instead of an 
older tribal classification, Compositae comprises over 1500 genera and around 
23,000 known species. They are arranged in three subfamilies, namely Asteroideae, 
Cichorioideae and Barnadesioideae, and seventeen tribes. Table 2.1 shows a brief 
overview of classification of Compositae, including the number of subtribes, genera 
and species. Each year, there are still more than 10 genera being described, therefore, 
it is far to achieve a stable and cladistic classification of Compositae (Bremer et al.， 
1994). 
Being the largest family of flowering plants, traditionally Compositae are also 
widely used as medicinal herbs in many countries with different functions. Therefore 
it is a valuable and tremendous source for scientists to explore and search for 
J bioactive natural products. 
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Although there are many species belonging to Compositae, Chinese regards 
the therapeutical actions of different varieties of Compositae plants practically same, 
i.e. they can "benefit the blood and circulation, preserve vitality and flowers are 
prescribed in colds, headaches, and inflamed eyes" (Smith, 1911). The white variety 
is claimed to be effective to prevent hair from falling out and keep in black, 
preventing turning to gray. 'Chrysanthemum wine' produced by soaking 
chrysanthemum flowers in wine is considered to be good for digestion, circulatory 
and nervous systems. The wild variety is used to treat retained menses, enlarged 
glands and wash infected and cancerous sores (Smith, 1911). 
More specific examples of traditional use of Compositae such as Wedelia 
chinensis, Hwang-hua-mih-tsay, is a Taiwanese folk medicine，used to treat swelling 
(Lin et al, 1994). Achillea millefolium, commonly called yarrow, is folkloric used to 
reduce fever and induce sweating (Tozyo, 1994). Roots of Ratibida mexicana is 
crushed and used by Tarahumara Indians to treat rheumatism of legs (Calera et ai, 
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Table 2.1 Classification of the Asteraceae, with number of subtribes, genera, and 
species (Adapted from Bremer et al, 1994). 
Subtribes Genera Species 
Asteraceae 82 1,535 23,000 
Barnadesioideae - 9 92 
Barnadesieae -- 9 92 
Cichorioideae 25 391 6,100 
Mutisieae 2 76 970 
Cardueae 4 83 2,500 
Lactuceae 11 98 1，550 
Vernonieae 6 98 1,300 
Liabeae - 14 160 
Arctoteae 2 16 200 
Asteroideae 57 1,135 16,200 
Inuleae __ 38 480 
Plucheeae - 28 220 
Gnaphalieae 5 181 2,000 
Calenduleae ~ 8 110 
Astereae 3 174 2,800 
. Anthemideae 12 109 1,740 
Senecioneae 3 120 3,200 
Helenieae 8 110 830 
Heliantheae 10 189 2,500 




2.3 Antitumor activity of Compositae 
Other than folkloric use, scientific publications on different bioactivities of 
Compositae are also available. For examples, hepatoprotective (Lin et al., 1994), 
antioxidatant (Chu et al., 1999) and antinociceptive effects (Block et al, 1998). 
One of the bioactivities that raised people's interest is the antitumor activity. It 
is also reported that many Compositae plants have this bioactivity (Kupchan and 
Bauerschmidt, 1971; Roussakis et al., 1984). Some recent publications about 
antitumor activity of Compositae include Emilia sonchifolia (Shylesh and Padikkala, 
2000), Silymarin (Chatterjee et al., 1999; Bedi and Shenefelt, 2002), Achillea 
millefolium, yarrow (Tozyo et al., 1994) and Parthenium hysterophorus (Mukherjee 
and Chatterjee, 1993). 
2.3.1 Emilia sonchifolia 
E. sonchifolia, a herbaceous plant found in Asia, is used as folklore medicine in 
India and China. It was reported to have cytotoxic effect on Daltons lymphoma (DL), 
Ehrlich ascites carcinoma (EAC) and mouse lung fibroblast (L-929) cells. 
In the in vitro cytotoxicity assay, the cell viability was determined by trypan 
J blue exclusion method. The methanolic extract of E. sonchifolia exhibited significant 
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cytotoxic effect towards DL, ECA and long term cytotoxicity towards L-929 with 
E C 5 0 at 1.5 mg/ml, 1 mg/ml and 15 ^ig/ml respectively. But no cytotoxicity was 
found on normal human lymphocytes (Shylesh and Padikkala, 2000). 
In the in vivo antitumor assay, effect against both ascites and solid tumor were 
investigated. Oral administration of the E. sonchifolia methanolic extract 
significantly increased the life span of EAC bearing mice, with 241 percent increase 
for mice received extract 24 h after tumor transplantation and 129 percent increase 
for mice received extract 10 days after tumor transplantation. The extracts also 
significantly reduced the DL solid tumor development in mice, from 4.25 cm^ tumor 
volume to 1.25 and 2.5 cm^ for mice received extract 24 h after tumor transplantation 
and mice received extract 10 days after tumor transplantation respectively (Shylesh 
and Padikkala, 2000). 
Other than antitumor activity, extracts of E. sonchifolia were also reported to 
possess antioxidant and anti-inflammatory activity (Shylesh and Padikkala, 1999; 
Muko and Ohiri, 2000) 
2.3.2 Silymarin 
J Silymarin is a naturally occurring polyphenolic flavonoid isolated from 
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Silybum mariamm, commonly known as milk thistle. Conventionally, silymarin is 
used for liver disease, with profound antioxidant effect, and is clinically used in 
Europe and Asia as an antihepatotoxic agent. Recent research conducted by 
Chatterjee et al. (1999) found that, silymarin like many other antioxidants, was an 
anti-tumor promotor agent, especially effective in protection against stage I tumor 
promotion. Stage I tumor promotion is an initial step, in which, initiated cell is 
converted to a dormant tumor cell (Chatterjee et al, 1999; Bedi and Shenefelt, 2002). 
In the in vivo assay, silymarin applied topically to SENCAR mouse before 
12-0-tetradecanoylphorbol 13-acetate (TPA) application resulted in a highly 
significant protection against chemically induced skin tumor promotion. The 
protective effects of silymarin was observed at the dose 3, 6, 12 mg per application in 
terms of (1) tumor incidence, with 25%, 40%, and 75% protection respectively; (2) 
tumor multiplicity (cumulative number of tumors per group or number of tumors per 
mouse), with 76%, 84%, and 97% protection respectively; and (3) tumor volume, 
with 76%', 94%, and 96% protection respectively. Moreover, in the in vitro assay, the 
DNA synthesis of human epidermoid carcinoma A431 cells was also inhibited by the 







2.4 Wedelia species 
Wedelia is a large genus of the family Compositae and belongs to the largest 
subfamily of Compositae, Asteroideae, tribe Heliantheae, subtribe Ecliptinae 
(Herz and Kulanthaivel, 1984). Many species of Wedelia are used in the folk 
medicine to cure a large variety of diseases in many countries, for examples, swelling, 
headaches, fevers, infections and pathologies of the respiratory tract (Roque et al, 
1987; Miles et al, 1990; Lin etal, 1994). 
2.4.1 Hepatoprotective effect 
Hepatoprotective effect is one of the bioactivities exhibited by several 
Wedelia species. Wedelia calendulacea was found to have antihepatotoxic activity, 
which counteracted the effects induced by hepatotoxin carbon tetrachloride (CCl-4), 
such as lowering the increase of liver weight, hepatic lipid peroxidation and serum 
alkaline phosphatase (Gopalakrishnan et al., 1989), The alcoholic extract of whole 
plant also elevated the bile flow in rats，which implied the stimulation of liver 
secretory capacity (Sharma et al, 1989). 
, Wedelia chinensis also possessed hepatoprotective effect. It is a Taiwan folk 
I 




tonic and useful folk medicine in treating coughs, headaches, skin disease, and 
baldness (Lily, 1980). The crude water extract of Wedelia chinensis at the dose of 
300 mg/kg, P.O. at 2，6，10 hours could reduce the increase of serum glutamate 
oxaloacetic transminase (SGOT) and glutamate pyruvic transaminase (SGPT) levels 
in acute hepatitis mice and rats which were induced by three well known 
hepatotoxins: CCl-4, acetaminophen for mice and D(+)-galactosamine for rats. 
Recently in Taiwan, it has been used as a remedy for hepatitis (Lin et al., 1994). 
2.4.2 Hypoglycemic effect 
Wedelia paludosa is a Brazilian medicinal plant. The extracts of this plant could 
significantly lower the blood glucose level in alloxan-induced diabetic rats by 
intragastical administration, implying that W. paludosa could be used as an adjuvant 
agent in treating diabetes (Novaes et al., 2001). 
2.4.3 Antimicrobial activity 
The n-hexane extract of Wedelia trilobata exhibited antimicrobial activity 
against both Gram-positive and Gram-negative bacteria, including Bacillus subtilis, 
Mycobacterium smegmatis, Staphylococcus aureus and Staphylococcus epidermidis, 
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which are Gram-positive; and Proteus vulgaris, Pseudomonas aeruginosa, 
Salmonella group C， Salmonella paratyphi, and Shigella sonnei, which are 
Gram-negative. The ethyl acetate extract, however was active against Salmonella 
group C only (Taddei and Rosas-Romero, 1999). 
2.4.4 Antinociceptive activity 
The hydroalcoholic extract of Wedelia paludosa, a Brazilian medicinal plant, 
which exhibited hypoglycemic effect, also possessed another bioactivity, the 
antinociceptive activity. Intraperitoneally administration of several fractions obtained 
from the hydroalcoholic extract of Wedelia paludosa at 3 mg/kg significantly 
reduced the number of abdominal constrictions induced by acetic acid in Swiss mice, 
including the contraction of abdominal muscle and stretching of hind limbs. The 
inhibition percentage of writhes was reported to be up to 72 percentage (Block et al, 
1998). 
2.4.5 Antifeedant and antifungal activities 
Stem extracts of Wedelia biflora, a Thai plant, showed antifeedant activity 
against the cotton boll weevil, and compounds isolated from the extracts also 
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exhibited antifeedant and/or antifungal activity (Miles et cd., 1990). Other 
compounds isolated from methylene chloride extract of leaves also exhibited 
antifeedent activity towards cotton boll weevil and/or antifungal activity (Miles et al., 
1993). 
2.4.6 Trypanosomicidal effect 
Diterpenes isolated from the ethanolic extract of Wedelia paludosa showed in 
vz>o trypanosomicidal effect. The isolated diterpenes could kill 100% of the parasitic 
protozoan Trypanosoma cruzi at the lowest dose of 0.68 mg/ml. Trypanosoma cruzi 
is a causative agent of Chagas, disease, also named American trypanosomiasis. The 
transmission vector is insect but recently, the major path of transmission is through 
infected blood in Brazil (Batista et al, 1999). 
2.4.7 Chemical constituents 
There' are several compounds commonly found in Wedelia species. These 
include lactone from Wedelia grandiflora (Bohlmann et al., 1984a), kaurenoic acid 
(diterpene) and flavone (flavonoid) from Wedelia paludosa which exhibit significant 




diterpene lactones from Wedelia regis (Bohlmann et al., 1984b), ent-kaurenic acids 
and lactones from Wedelia hispida, ent-kauranes from Wedelia calycina (Herz and 
Kulanthaivel, 1984), eudesmanolides, diterpene and sesquiterpene lactones from 
Wedelia trilobata (Bohlmann et al, 1981)，eudesmanolide sesquiterpenes from 
Wedelia prostrata (Farag et al., 1996), sesquiterpene lactone, wedelolactone, 
(C16H10O7) from Wedelia chinensis (全國中草藥匯編編寫組，1983)，and diterpenes 




2.5 Sesquiterpene lactones 
Sesquiterpene lactones are a group of naturally occurring compounds with three 
isoprene units, 15 carbon atoms, lactone structure, and usually with different degree 
of unsaturation. The empirical formula of sesquiterpene is C15H24. Sesquiterpene 
lactones can be found in both higher and lower plants, and they are characteristic 
compounds in compositae plants as secondary metabolites with different structure. 
They are colorless and bitter. The boiling point of sesquiterpenes is relatively high, 
usually between 250�C and 280�C (Rodriguez et al, 1976; Ragasa et al., 1993;肖祟 
厚，1996). 
Sesquiterpene lactones are classified basically by the carbocyclic skeletons 
(Rodriguez et al., 1976). Typically occurring sesquiterpene lactones in compositae 
plants include germacranolides, eudesmanolides, guaianolides, pseudoguaianolides 
and xanthanolides (Ragasa et al., 1993; Dirsch et al., 2001). Very often, lactones 
with highest concentration in leaves and flowering heads, the percentage vary with 
species, and in some species the content also vary with seasons (Rodriguez et al., 
1976). 
Many sesquiterpene lactones were isolated and identified during the past 50 




also in great interest. Sesquiterpene lactones were documented with diverse 
biological activities, including antitumor and cytotoxic activity, antimitotic activity, 
antimicrobial activity, chemoprophylaxis, allergic effect on man, antifeedant acticity 
on insect, poisoning activity on vertebrate, plant growth regulatory activity, and 
preventive activities on crop diseases (Rodriguez et al, 1976; Ando et al., 1987). 
Many publications related the biological activities of sesquiterpene lactones to 
the lactone structure, with a-methylene y-lactones moiety or a,P-unsaturated lactone 
moiety (Lee et al, 1971; Rodriguez et al, 1976; Ando et al., 1987;肖祟厚，1996; 
BQQkmmet al, 1998). 
Artemisinin (Beekman et aL, 1998), helenalin (肖祟厚，1996; Dirsch et aL, 
2001)，vernolepin (肖祟厚，1996) and parthenolide (Kang et al, 2002) are examples 
of sesquiterpene lactone with antitumor activity. Moreover, Arglabin-DMA, the 
derivative of arglabin, a sesquiterpene lactone from Artemisia glabella is registered 
as a compound with antitumor activity in the Republic of Kazakstan (Shaikenov et 
a/., 2001).‘ 
Although cytotoxicity of sesquiterpene lactones is believed to be related to the 
reaction with sulfhydryl groups via a Michael-type addition, one of the antitumor 
sesquiterpene lactones that have been widely investigated, Helenalin, was reported to 
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induce apoptosis in human leukemia Jurkat T cells but not in healthy human 
peripheral blood mononuclear cells (PBMCs). The apoptosis-inducing mechanism of 
helenalin was demonstrated to involve the activation of caspase-3, downstream 
effector and caspase-8, the initiator and cytochrome-c release from mitochondrioa to 
cytosol. Moreover, the apoptosis-inducing mechanism was independent of CD95 
death receptor and antiapoptotic proteins BCI-XL and Bcl-2 (Dirsch et aL, 2001). 
Another example, parthenolide, was reported to be able to uplift the 
differentiation of human leukemia HL-60 cells into monocytes induced by 
l,25-(OH)2D3. And this enhancement was suggested to be the ability of parthenolide 






2.6 Cell cycle control and apoptosis 
It is very important for multicellular organisms to maintain the balance of cell 
proliferation and programmed cell death. If the homeostasis of these two events were 
disrupted, it would be a great problem and may lead to vary diseases. Cancer is 
recently recognized as a disease caused by both uncontrolled cell proliferation and 
ineffective cell death. Therefore, cell cycle control and apoptosis have become two 
major targets for cancer therapy. 
2.6.1 Cell cycle and its control in cancer therapy 
Each normal cell passes through a tightly controlled cell cycle in order to grow 
and divide. There are many events associated with the cell cycle, and these events are 
orderly distributed in different phases of cell cycle, namely M phase, G1 phase, S 
phase and G2 phase (Figure 2.3). In mammalian cells, generally, the time required 
for one cycle is about 18-24 hours (Becker et al, 2000). 
I 
In M phase, also known as mitotic phase, mitosis and cytokinesis take place in 
series, which means the events of nuclear division and cytoplasmic division take 
place respectively. After the division of cytoplasm, two daughter cells are produced 
with identical DNA content. Therefore, the point of actual division of cell occurs in 
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the M phase. 
There are many dramatic events in mitosis, include (1) the condensation of 
chromatin to produce thick chromosomes which can be seen under microscope; (2) 
breakage of nuclear envelop; (3) segregation of sister chromatids by mitotic spindle 
to opposite poles of cell; (4) cytokinesis and formation of new nuclear envelop. 
However, the time spent in mitotic phase by mammalian cell is relatively short, 
usually less than an hour although it varies among different cell types (Becker et al., 
2000). 
Cells spend much more time in the interphase, which is a growth phase, made 
up of Gl, S and G2 phases. During interphase many cellular components are 
synthesized and so lead to gradual increase in cell mass. In S phase DNA is 
synthesized, and it usually takes six to eight hours in mammalian cell. 
In between M phase and S phase, there are two gaps, the first one is Gl 
phase, which separates M phase to S phase; the second one is G2 phase, which 
separates cells to pass from S phase back to M phase and to undergo division again. 
Other than the four phases mentioned above, there are three check points in 
the cell cycle so as to make sure � the corresponding events of each phase undergo 
in suitable time and correct sequence; (2) the associated events in each phase have 
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completed before the cell entering the next phase; and (3) allow the cell to respond to 
external stimuli, for examples, nutrient supply, cell density and growth-signaling 
molecules. The three check points are G1 check point, G2 check point and spindle 
assembly checkpoint (Becker et al, 2000; Thomas, 1996). 
G1 check point, also known as restriction point in animal cells, is located 
late in G1 phase, critical check for cells entering S phase. Mammalian cells arrested 
from division are usually arrested in Gl. And cultured cells in exhausted nutrients or 
overcrowding are also arrested at Gl. In this checkpoint, cell size, nutrients, growth 
factors and DNA damage are checked before allowing cells to pass through. For 
those, which cannot pass through Gl checkpoint, can be indefinitely retained in Gl, 






Figure 2.3 Diagram of cell cycle and the checkpoints. 
G2 check Spindle assembly 





The second checkpoint is G2 checkpoint, located in the G2/M boundary. In 
some cell types, if cell division is not required, cells are remained at this point 
indefinitely. Cell size and DNA replication are checked at G2 checkpoint, therefore, 
in order to pass through G2 phase into M phase, DNA synthesis must be completed 
(Becker et al., 2000; Thomas, 1996). 
The third cell cycle checkpoint is the spindle assembly checkpoint located at 
the boundary between metaphase and anaphase. It checks for the proper attachment 
of mitotic spindle to chromosome. It is very important because it ensures the newly 
formed daughter cells to contain identical and complete set of chromosomes. For 
cells with defects in the spindle attachment, temporary arrestment is found (Becker et 
al., 2000; Thomas, 1996). 
The factors, including completion of associated events in each phase and 
growth factors, affecting cell behaviour in the checkpoints are mediated by cellular 
proteins, such as cyclins, cyclin-dependent kinase (Cdk) and retinoblastoma protein 
i 
(pRb). Cyclins are a group of proteins that activate another group of protein kinase 
called Cdk, and form the Cdk-cyclin complex. The interaction between Cdk and its 
corresponding cyclins plays a critical role to regulate cell cycle. The G1 checkpoint 
^ y s controlled by G1 Cdk-cyclin complex, while the complex is controlled by the 
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phosphorylation of pRb. 
In G1 phase, cyclin D conjugates with Cdk-4 and phosphorylates pRb to 
release it from and activate E2F, which is a transcription factor to initiate gene 
transcription of enzymes and proteins required for S phase, so cells can pass through 
G1 checkpoint into S phase to synthesize DNA. On the other hand, 
hypophosphorylated pRb binds to E2F, therefore can prevent cells entering into S 
phase. So, Rb gene is also known as tumor suppressor gene, and serves as a brake to 
inhibit transition from G1 to S phase when no appropriate signal from a growth 
factor is present. Mutation of Rb gene that leads to non-functional pRb and causes 
uncontrolled cell proliferation has been detected in cancers, for examples, lung, 
breast，bladder cancers and hereditary retinoblastoma in child. Therefore, antitumor 
drugs that can inhibit cyclin D, Cdk-4 or induce dephosphorylation of pRb are 
capable to inhibit the proliferation of cancer cells (Thomas, 1996). 
For example, a naturally occurring red pigment isolated from marine sponge, 
fascaplysin, which arrests U20S (osteosarcoma) in G1 phase by inhibiting Cdk-4 
from phosphorylating pRb, therefore, arrests cell growth. The determination of G1 
arrest was done by flow cytometry and decreased Cdk-4 could be examined by 
乂weste rn blot and immunodetection (Soni et al., 2000). Another example, Oxindole I 
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inhibited the proliferation of human mammary carcinoma cell lines MCF-7, ZR-75-1 
and BT-549 and Urea II inhibited the proliferation of MCF-7 and BT-75-1. Both 
Oxindole and Urea II were reported to inhibit cyclin Dl-Cdk-4 complex. It 
demonstrated the importance of inhibiting cyclin Dl-Cdk-4 complex to induce 
phosphorylation of pRb, which in turn, blocked the transition from G1 to S phase in 
cancer therapy (Kent et al., 1999). 
Other than resting in G1 checkpoint, anticancer therapy may be mediated by 
arresting tumor cells proliferation in the second checkpoint, G2 checkpoint located in 
G2/M boundary. It was reported that dietary flavone reduces the proliferation of 
human colon carcinoma cell line HT-29 and the effects are related to G2/M arrest 
(Wenzel et al.’ 2000). Besides, analogues of halichondrin B (polyether macrolide 
found in marine sponges), ER-076349 and ER-086526 inhibited the proliferation of 




Cell numbers in multicellular organisms are regulated by the homeostasis of 
I 
I 
proliferation and programmed cell death. As the regulation of proliferation through 
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cell cycle regulations has been discussed above, cell death through apoptosis will be 
discussed in this part. 
"Apoptosis is a form of cell death that plays important roles in physiological 
and pathological phenomena" (Tanuma and Shiokawa, 1996). Cancer can be 
described as uncontrolled cell growth. Therefore apoptosis also plays an important 
role against oncogenesis, because it likes a suicide mechanism and serves as a means 
to remove undesired cells from the body, for examples mutated cells and infected 
cells. 
Although the term programmed cell death (PCD) and apoptosis are widely used 
interchangeably, but actually, "PCD is an operational definition of a functional 
relationship in development, whereas apoptosis is an originally morphological, but 
now biochemical description of a mode of cell death" (Lockshin and Zakeri, 1991). 
PCD may not accompany with apoptosis although they are often observed together 
(Gupta, 1996). 
When talking about apoptosis, the other form of cell death, necrosis, is 
usually mentioned. Recently, the term of necrosis was proposed to represent the 
events after cell death. And the term oncosis should be used instead of necrosis to 
describe the events that cause the cell death by cell swelling and membrane 
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disruption and finally lead to inflammation (Lockshin et al., 1998; DeBlois et al, 
2000). 
Unlike oncosis, morphological characteristics of apoptotic cells include cell 
shrinkage, condensation of cytoplasm and chromatin, migration of the condensed 
chromatin to the margin of nuclear envelop, budding of nuclear and plasma 
membrane to form membrane-bounded apoptotic bodies. The biochemical 
characteristics include changes in plasma membrane surface, protein synthesis and 
internucleosome cleavage of DNA (Cameron and Feuer, 2000). 
To detect apoptosis, researchers usually use flow cytometry or 
internucleosomal cleavage detection method. Agarose-gel electrophoresis method, 
which determines DNA fragmentation qualitatively, is the commonest detection 
method to detect internucleosomal cleavage. The principle behind this method is that, 
in apoptotic cells, as the constitutive endonucleases activated by some signal 
transduction pathway attack the DNA inter-nucleosomes regions, cleave the DNA 
into non-random oligonucleosomal fragment, with 180-220 base pair and multiples 
of this unit. Since this ordered fragmentation is a hallmark of apoptotic cells, it is 
commonly used as a marker of apoptosis. This characteristic can be expressed as 
夕DNA ladder (ladder of DNA bands) on agarose electrophoresis gel (Cotter and 
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Martin, 1996; DeBlois et al, 2000). 
As mentioned before, cell proliferation is only one part that contributes to 
tumor growth, and cell death is the other part. Therefore, for cells that are unable to 
carry out normal apoptosis due to mutation of genes that execute apoptosis, drugs 
that activate or induce apoptosis can serve as a new target in cancer therapy, and this 
is one of the 'heat' topics in this field. 
For example, doxorubicin (DOX) is a current drug commonly used to cure 
hepatocellular carcinoma (HCC). Its effect was reported mainly due to apoptosis. 
DOX exhibited cytotoxic effect on human HCC cell lines, Hep3B and Huh-7, and 
human hepatoblastoma cell line HepG2. Apoptotic peak revealed by flow cytometry 
was observed in all cell lines after treatment of DOX accompanied with DNA 
fragmentation revealed by agarose gel electrophoresis (Lee et al.’ 2002). 
Other than current drugs, natural products also exhibited the same effect on 
cancer cells. The aqueous extract of Salvia miltiorrhiza (SM), a herb that is used in 
traditional Chinese medicine to cure liver diseases, showed antitumor activity against 
HepG2. Aqueous extract of SM inhibited the growth of HepG2 to 37.6% of the 
control at 2.5 mg/ml. The mechanism behind the antitumor activity was studied to be 
t I 
I 
\ related to apoptosis, and DNA fragmentation was also observed (Liu et al, 2000). 
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Magnolo, a hydroxylated biphenyl compound obtained from Chinese medicinal herb 
Magnolia officinalis, inhibit the cell growth of human colon cancer cell line, 
COLO-205 in vitro and in vivo and HepG2 in vitro. The antitumor effect was 
reported to be mediated by apoptosis with DNA fragmentation too (Lin et al, 2002). 
Apoptosis with DNA fragmentation were also observed in other cell lines, for 
examples leukaemia cell lines, HL-60 and K-562. Sogawa et al. (1998) demonstrated 
that marine microalgal polysaccharide exhibited strong cytotoxicity to K-562 cells in 
vitro and induced apoptosis. On DNA gel electrophoresis, DNA laddering was also 
observed. Besides, squamocin, one of the annonaceous acetogenins, is bioactive 
secondary plant metabolite, with a long alkyl chain and unsaturated 
r-methyl-r-lactone at the terminal, had potent antiproliferative effect on HL-60 cells 
in vitro. Squamocin was reported to induce apoptosis in HL-60 cells and activate 
caspase-3, and DNA laddering was also observed in agrose gel electrophoresis (Zhu 
et al, 2002). Caspase is a family of cystein protease. Now, more then fourteen 
caspases' have been identified and many are involved in apoptosis. Caspase-3 is an 
effector caspase, like an apoptotic executor, induces apoptosis once activated by 
different apoptotic signal (Nunez et al., 1998). Therefore, measuring the activation 
j level of caspase-3 can also reflect the occurrence of apoptosis and commercially 
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available kit can be used for the measurement of caspase-3 related protease activity. 
Zhu et al (2002) also concluded that caspase-3 take a critical role in the activation of 
apoptosis in HL-60 cell by squamocin. In another study, caspase-3 was also reported 
to be related to the anticancer effect of dietary flavone against human colon 
carcinoma cells HT-29. Flavone (2-phenyl-4H-1 -benzopyran-4-one) was reported to 
be able to reduce HT-29 cells proliferation, and induce apoptosis. Moreover DNA 
fragmentation was observed in flavone treated HT-929. Besides, flavone could 
activate caspase-3, which was reported as the most downstream enzyme to execute 
apoptosis (Wenzel et aL, 2000). 
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2.7 Four selected Compositae species used in the study 
Dendranthema indicum, Dendranthema morifolium. Taraxacum mongolicum 
and Wedelia thlobata are all Compositae species and were selected to study their 
antitumor activity in this project. 
2.7.1 Dendranthema indicum (里予菊花) 
Dendranthema indicum, (Ye Jiu Hua, wild chrysanthemum flower), is small 
wild chrysanthemum with yellow flowers, distributed throughout China (Smith, 
1911), which are favorite autumn and winter flowers. The flowering seasons are in 
the autumn and winter and this herb is collected when flowers just bloom. 
In traditional description, the properties of Dendranthema indicum are bitter, 
pungent and slightly cold. The flowers are traditionally used to remove toxic-heat, 
treat inflammation of eyes, boils and carbuncles, relieve red swollen eyes, headache 
and dizziness caused by high blood pressure. The ethanolic extract of flowers also 
posses hypotensive effect in rats, cats and dogs. Moreover, it is used to treat retained 
menses, foment enlarged glands, as a wash in infected and cancerous sores and 
relieve sore swollen throats. The decoction of flowers has anti-infectious effect 
against Shigella dysenteriae and several other pathogenic bacteria in vitro. Besides it 
^ ^ ， 
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can increase the phagocytic function of human leukocytes against Staphylococcus 
aureus. Furthermore, the distillate of stem and leaf of the herb is applied in acute 
bronchitis to relief symptoms of fever, cough and asthma. (Wang, 1983;中華人民共 
和國衞生部藥典委員會，1990; Zhu, 1998; Li, 2002). 
2.7.2 Dendranthema morifolium (菊花) 
Dendranthema morifolium (Jiu Hua)，is a perennial herb. The dried anthodium 
is used as Chinese traditional medicinal herb. It is collected in its flowering seasons 
from September to November. During this period, the flowers are in full blossom. 
(Zhu, 1998) 
Flowers of Dendranthema morifolium are traditionally described to be sweet 
yet bit and slight cold, used to expel wind-heat, relieve red swollen eyes, headache 
and dizziness, hypertension, blur vision, as antitoxin, remedy for common cold, for 
liver claming and heat-clearing, and upper respiratory infection. The decoction of the 
flower is used to treat coronary diseases and hypertension, effectively relief chest 
discomfort, palpitation, tachypnea, dizziness, headache and numbness of the 
extremities. Although a side effect of epigastralgia or diarrhea was reported in few 
cases，in acute and subacute toxicity tests conducted by Zhu (1998) no strong 
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toxicity was reported (中華人民共和國衞生部藥典委員會,1990; Li, 2002). 
2.7.3 Taraxacum mongolicum (蒲公英) 
Taraxacum mongolicum, with common name dandelion, is collected at the 
flowering seasons, which starts from spring to autumn. The dried herb is used as 
traditional Chinese medicine with sweet yet bit and cold characteristics, with tonic 
property, functioning at the liver and stomach. It is used to remove toxic-heat, excess 
salt and water, induce subsidence of swelling, diuresis, relief dysuria, excreting 
dampness, relieve breast abscesses, sore throat, swollen red eyes and painful, 
indigestion, jaundice, and as antispirochetic agent. In clinical application, the herb 
was reported to increase bile flow and relieve pain in chronic gallbladder spasm. The 
shoot of Taraxacum mongolicum is so tender, can be eaten as a pot-herb. The herb is 
reported to have low toxicity, induce occasional gastrointertinal reactions, for 
examples, mild diarrhea and abdominal discomfort. (Smith, 1911;中華人民共禾口國 





2.7.4 Wedelia trilobata (三裂葉膨棋菊） 
Wedelia trilobata, with common name yellow wedelia, is an evergreen 
perennial, scrambling herbaceous plant introduced into Hong Kong. The country of 
origin is South America. It flowers in summer and can be found in many public 
gardens as a very attractive decorative ground cover. Stems are round, rooting at the 
nodes, with three-lobed opposite stalkless leaves. The two lateral lobes found at 
about the middle of the leaf and the upper surface of leaves is in dark shining green 
color. Wedelia trilobata are widely spread and making a dense ground cover 
(Thrower, 1984). 
Wedelia trilobata belongs to the division Magnoliophyta, class 
Magnoliopsida, subclass Asteridae，order Asterales, family Asteraceae, subfamily 
Asteroideae, tribe Heliantheae, subtribe Ecliptinae. Other than decorative purpose, it 
is used in traditional medicine. The crushed leaves are used as poultice, to relief 
discomfort symptoms of colds and flu by the tea preparation, and the herb can be 
used to 'clear the placenta after birth when used in combination with other herbs. 
Traditionally, this plant is also used to treat hepatitis, indigestion, and infections. 
Other than traditional use, in scientific research, the n-hexane extract and 
ethylacetate extract of Wedelia trilobata exhibited antimicrobial activity against both 
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Gram-positive and Gram-negative bacteria (Taddei and Rosas-Romero, 1999). 
Although there were several researches studied on the constituents of Wedelia 
trilobata, researches on the bioactivities are relatively less and research on the 
antitumor effect is even more seldom. 
t 
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Chapter 3 
Materials and Methods 
3.1 Extraction 
3.1.1 Water extraction 
Fifty grams of dried flowers respectively of Dendranthema indicum (DI), 
Dendranthema morifolium (DM) and whole plant of Taraxacum mongolicum (TM) 
purchased from Guangzhou supplier were boiled separately with 500 ml distilled 
water for 1 h for two times. The water extracts were collected after gauze filtration and 
centrifuged at 22095 g for 30 min by Beckman J2-MI centrifuge. The supernatant 
collected were then concentrated at 60°C by rotary evaporator (BuCHI Rotavapor 
R-200) at reduced pressure and named as DIl, DM1 and TMl respectively. 
Two kilograms of fresh aerial parts of Wedelia trilobata (WT) collected on the 
campus of the Chinese University of Hong Kong (CUHK) during the month April 
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2001 was washed and boiled at 90 - 100°C with distilled water for 5 min. WT was then 
homogenized with 6 L distilled water by blender and boiled overnight (16 h) in slow 
cooker. After gauze filtration, the filtrate was collected. The residue was boiled with 
another 6 L distilled water overnight (16 h) again and filtrate was collected after 
filtered by gauze. The two filtrates obtained were pooled together and centrifuged at 
22095 g for 30 min. The supernatant was collected and concentrated to 1.2 L at 60�C 
by rotary evaporator at reduced pressure, named as WT 1. 
3.1.2 NaOH extraction 
Firstly, 1% NaOH was added to the residue obtained after water extraction with 
stirring and kept overnight (16 h). Secondly, the base extract was centrifuged at 22059 
g for 30 min, the supernatant was collected and neutralized with HCl. Thirdly, it was 
centrifuged at 22059 g for 30 min and concentrated at 60°C by rotary evaporator at 
reduced pressure. Finally, dialysis extensively against distilled water to remove salts 
by pore'size 12-14 kDa dialysis tubing and lyophilized by freeze drier. WT2 was 
assigned to represent this extract. 
/ 
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Figure 3.1 (a) Wedelia trilobata in the CUHK and (b) Wedelia trilobata collected for 
extraction. 
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3.1.3 Ethanol precipitation 
Firstly, 95% ethanol was slowly added to WTl with stirring to make up final 
concentration of 68% ethanol. It was kept overnight (16 h) with stirring. Secondly, it 
was centrifuged at 22095 g for 30 min, supernatant and precipitate were both 
collected. 
In the supernatant, ethanol was removed by rotary evaporator at 40�C and 
reduced pressure. Then the supernatant without ethanol was named WT4 and 
lyophilized by freeze drier. 
The precipitate was resuspended in distilled water, named as WT7, and 
t 
lyophilized by freeze drier. 
3.1.4 Bioactivity guided fractionation 
3.1.4.1 Macroporous resin column (Dioi) 
Two grams of WT4 dissolved in distilled water was loaded into a 3.6 x 40 cm 
Dioi macroporous resin column (天津農總廠 ) a t flow rate 0.7 ml/min. It was eluted 
with distilled water, 15% ethanol, 30% ethanol and 60% ethanol one by one, each for 
four bed volumes, four fractions named WT4-1, WT4-2, WT4-3 and WT4-4 were 
collected respectively. 
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The ethanol in WT4-2, WT4-3 and WT4-4 were removed by rotary evaporator at 
40°C and reduced pressure. Then all the four fractions were lyophilized by freeze 
drier. 
3.1.4.2 Silica gel 60 column 
An amount of 300 g WT4-4 was dissolved in 2 ml methanol, then mixed with 1 g 
silica gel 60 and dried. The sample was chromatographed on a 30 g silica gel column 
(Silica gel 60, 0.063 - 0.200mm, Merck), eluted with 100 ml chloroform: ethyl acetate: 
n-hexane: methanol (3:1:1:0.5) to obtain WT4-4 A, another 100 ml chloroform: ethyl 
acetate: n-hexane: methanol (3:1:1:0.5) to obtain WT4-4 B, then 100 ml chloroform: 
ethyl acetate: n-hexane: methanol (2:1:0.5:1) to obtain WT4-4 C and finally 100 ml 
methanol to obtain WT4-4 D. WT4-4 A was then concentrated by rotary evaporator at 
50°C and reduced pressure. The concentrated fraction WT4-4 A was allowed to settle 
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Figure 3.2 Flow chat illustrating the simplified extraction and fractionation of 
I Wedelia trilobata. 
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3.1.5 High Performance Liquid Chromatography (HPLC) analysis 
WT4-1, WT4-2, WT4-3, WT4-4, WT4-4 A, WT4-4 B, WT4-4 C, WT4-4 D and 
the crystal isolated from WT4-4 A were subjected to HPLC analysis (Hewlett Packard 
series 1100). Reverse-phase HPLC was performed on Bio-Rad Bio-Sil C18 HL 90-5 
column (250 x 4.6 mm, particle size: 5 |im) with mobile phase 1% acetic acid and 
methanol (40:60, v/v), at the flow rate 0.8 ml/min or 0.5 ml/min, column temperature 
30°C and the detection wavelength 210 nm. 
WT4-1 was dissolved in methanol to water in 40:60 ratio. WT4-2 was dissolved 
in methanol to water in 80:20 ratio. WT4-4 A, WT4-4 B and the crystal were dissolved 
in methanol to chloroform in 60:40 ratio. WT4-3, WT4-4，WT4-4 C and WT4-4 D 
were dissolved in methanol. All the samples were filtered with 0.45 filter before 
HPLC analysis. 
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3.2 Characterization 
3.2.1 Chemical tests 
Unless otherwise stated, WT4-4 was dissolved in methanol (Img/ml) and used in 
the chemical tests to detect various phytochemical groups. WT4-4 was tested against 
the presence of alkaloids, lactones and coumarins, flavonoids, sterols and saponins, 
carbohydrates and polyglucose, terpenoids and anthraquinone. 
3.2.1.1 Alkaloids 
3.2.1.1.1 Mayer reagent 
An amount of 1.36 g HgCb and 5 gKI was dissolved in 60 ml and 10 ml distilled 
water respectively, and then make up to 100 ml. After adding with sample and few 
drops of HCl, if alkaloids presence, yellowish precipitate would form (Silva et cd., 
1998). 
3.2.1.1.2 Dragendorff reagent 
Eight grams of Bi(N03)3.H20 in 17 ml 30% H N O 3 and 27.2 g KI in 50 ml 
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made up to 100 ml with distilled water. After adding the sample, if alkaloids were 
present, orange-brown precipitate would form in acidic pH (Silva et al.’ 1998). 
3.2.1.1.3 Wagner reagent 
An amount of 1.27 g I2 and 2 g KI was dissolved in 100 ml distilled water. Few 
drops of the solution were added to the sample in acidic pH (diluted H 2 S O 4 ) . If 
alkaloids were present, brown precipitate would form (Silva et cd., 1998). 
3.2.1.2 Lactones and coumarins 
3.2.1.2.1 Ferric hydroxamine acid test 
Seven grams of N H 2 H 2 O HCI was dissolved in 100 ml distilled water. 5.6 g 
potassium hydroxide was dissolved in 100 ml methanol. 1 g ferric chloride was 
dissolved in 100 ml 1% HCl. The three solutions were mixed together in sequence just 
before use. A few drops of mixed solution were added to the sample. Red color would 
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3.2.1.2.2 Emersen reagent 
Two grams of ampyrone was dissolved in 100 ml ethanol. 8 g potassium 
ferricyanide was dissolved in 100 ml distilled water. The two solutions was mixed just 
before use. A few drops of mixed solution were added to the sample. Red color would 
indicate the presence of lactones or coumarins (肖祟厚，1996). 
3.2.1.3 Flavonoids 
3.2.1.3.1 Shinoda test 
Magnesium powder and a few drops of concentrated HCl (37%) were added to 
the sample. Orange, pink, red to purple colors would indicate the presence of flavones 
or flavonols (Silva et al., 1998). 
3.2.1.3.2 Aluminum chloride reagent 
A few drops of 2% aluminum chloride in methanol were added to the sample. 
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3.2.1.4 Sterols 
2.2.1.4.1 Liebermann-Buchard test 
One milliliter anhydrous acetic acid and 1 ml chloroform were mixed and cooled 
to 0�C. One drop of concentrated sulfuric acid (98%) was added to the solution. 
Sample dissolved in chloroform was then added to the solution, blue, green, red or 
orange colors which change with time would represent the presence of sterols (Silva et 
al., 1998). 
3.2.1.4.2 Salkowski reaction 
Two milligrams of sample was dissolved in 1 ml chloroform and mixed with 1 ml 
concentrated sulfuric acid (98%), two phases formed, with red or yellow color would 
represent the presence of sterols or methylated sterols (Silva et al, 1998). 
3.2.1.5 Saponins 
Five milligrams of sample was dissolved in 10 ml distilled water and shaked. 
Foam formed and stable for 15 min or more would represent the presence of saponins 
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3.2.1.6 Carbohydrates 
3.2.1.6.1 Molisch reagent 
Two to three drops 1% a-naphthol in 80% ethanol and concentrated H2SO4 (98%) 
were added to sample without mixing to form two phases. Purple ring appear in the 
interface would represent the presence of carbohydrates (Silva et al, 1998). 
3.2.1.6.2 Aniline acetate reaction 
Sample in solid form was heated on flame. Filter paper impregnated with aniline 
acetate was place on top of the sample to allow the vapors of sample to react with it. 
Red color in filter paper would indicate the presence of heterocyclic aldehydes 
produced by carbohydrate dehydration (Silva et al, 1998). 
3.2.1.7 Terpenoids 
3.2.1.7.1 Vanillin reagent 
Ah amount of 0.5 g vanillin was dissolved in 80 ml concentrated sulfuric acid 
(98%) and then made up to 100 ml with ethanol. Few drops of the solution were added 
to the sample. Red to purple color would indicate the presence of terpenoids (肖祟厚， 
1996). 
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3.2.1.7.2 Carr-price reagent 
Five grams of antimonous chloride was dissolved in 25 ml chloroform. Few 
drops of the solution were added to the sample. Orange color in UV light (366 nm) 
would represent the presence of terpenoids (肖祟厚，1996). 
3.2.1.8 Anthraquinone 
3.2.1.8.1 Borntrager reaction 
Five grams of potassium hydroxide was dissolved in 50 ml distilled water. A few 
drops of the solution were added to the sample. Red color would represent the 
presence of the anthraquinone (肖祟厚，1996). 
3.2.1.8.2 Magnesium acetate reagent 
An amount of 5 g magnesium acetate was dissolved in 50 ml methanol. A few 
drops of the solution were added to the sample. Orange, red to purple colors would 
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3.2.2 X-ray crystallography 
The crystals obtained from WT4-4 A was subjected to X-ray 
crystallographic analysis: C 2 3 H 3 2 O 9 , Mr = 452.49, hexagonal, P 6 5 , a = 9.8327(4), c = 
42.600(2) A, V = 3566.8(3) k\Z=6, dx = 1.264 M g W , F(000)= 1452, |^(Mo-Ka)= 
0.097 mm''. Data collection was performed on a SMART 1000 CCD using graphite 
monochromated radiation {X = 0.71073 A), 4174 unique reflections were collected to 
6hiax = 25.00°, in which 3665 reflections were observed [F^ > 4c(i^)]. The structure 
was solved by direct method (SHELXTL version 5.1) and refined by full-matrix 
least-squares on F^. In the structure refinements, non-hydrogen atoms were refined 
anisotropically. Hydrogen atoms bonded to carbons were placed on the geometrically 
ideal positions by the 'ride on’ method. Hydrogen atoms bonded to oxygen were 
located by the difference Fourier method and were included in the calculation of 
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3.3 In vitro Assay 
3.3.1 Cell lines 
Human acute promyelocytic leukemia HL-60 cells, human chronic myelogenous 
leukemia K-562 cells, mouse Sarcoma S-180 cells, human hepatoblastoma HepG2 
cells and monkey kidney Vero cells were purchased from American Type Culture 
Collection (ATCC). Human breast cancer MCF-7 cells and human liver L-02 cells 
were obtained from the Institute of Genetics, Fudan University, Shanghai. 
HL-60, K-562 and S-180 are suspension cell lines while HepG2, Vero, MCF-7 
and L-02 are adhesive cell lines. 
3.3.2 Maintenance of cell lines 
All the media used were added with 1% penicillin (10,000 
unit/ml)-streptomycin (10,000 |ig/ml) (Gibco-BRL) and 0.1% fungizome 
(amphotericin B 250 juig/ml) (Gibco-BRL). 
‘HL-60, K-562, HepG2 and MCF-7 were maintained in RPMI 1640 medium 
(Sigma) supplemented with 2 g/L sodium bicarbonate (Sigma), 10% heat-inactivated 
(56°C for 60 min) fetal bovine serum (Gibco-BRL). 
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S-180 cell line was maintained in Dulbecco's Modified Eagle Medium 
(DMEM) (Gibco-BRL), high glucose, supplemented with 10% heat-inactivated fetal 
bovine serum and 1.5 g/L sodium bicarbonate. 
Vero cell line was maintained in Minimal Essential Medium (MEM) 
(Gibco-BRL) supplemented with 10% heat-inactivated fetal bovine serum, 20 mM 
Hepes, 2 mM glutamine and 0.6% 4 mg/ml gentamycin. 
L-02 cell line was maintained in Iscove's Modified Dulbecco's Medium 
(IMDM) (Gibco-BRL), supplemented with 10% heat-inactivated fetal bovine serum 
and 3.024 g/L sodium bicarbonate. 
All the cell lines were cultured in 25 cm^ sterile polystyrene tissue culture flask 
(Sarstedt) with 10 ml medium for suspension cell lines or 5 ml medium for adhesive 
cell lines. All the cell lines were maintained at fully humidified atmosphere at 37°C, 
5% CO2 and 95% room air, with three times passage per week. 
3.3.3 In vitro antitumor assay 
The direct cytotoxicity of samples on different cancer cell lines were investigated 
by direct incubation of cancer cell lines with samples for 72 h. The effects were 
� evaluated by two methods according to the type of cell lines. Trypan blue exclusion 
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method was used for suspension cell lines and MTT assay method was used for 
adhesive cell lines. 
3.3.3.1 Trypan blue exclusion method 
Loss of membrane integrity is one of the morphological characteristics in death 
cell. Therefore, Trypan blue dye can stain death cells while viable cells can exclude 
this dye (Cotter and Martin, 1996). The in vitro antitumor effect against suspension 
cancer cell lines HL-60, K-562 and S-180 were revealed by Trypan blue exclusion 
method. 
Water insoluble samples were dissolved in dimethylsulfoxide (DMSO) (Sigma) 
as stock while water soluble samples were dissolved in phosphate buffered saline 
(PBS) as stock. 
In this assay, stock samples were diluted by corresponding medium to 2-fold 
higher concentration of the desired final concentration. 50 |j.l/well of 5 x lO* selected 
tumor cells/ml medium were seeded into a sterile 96-well round bottom tissue culture 
microplate (IWAKI, Japan) and mixed with 50 [i\ sample/well. Final concentration of 
DMSO was kept at 0.5% (v/v) for water insoluble sample in each well. Wells with 50 
0.5% DMSO in medium (water insoluble sample) or PBS instead of sample were 
/ 
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used as control. Each concentration was performed in triplicate. The culture plate was 
incubated at fully humidified atmosphere with 37°C, 5% CO2 and 95% room air for 72 
h. 
After 72 h incubation, 100 |li1 filtered 0.4% Trypan blue (w/v) in PBS was added 
to each well. After 2-3 min for uptake of dye, aliquot of cells suspension from evenly 
mixed wells was transferred to hemocytometer (Hausser Scientific, USA) and covered 
with cover-slip. Viable cells and dead cells in the four 1 mm^ corners were both 
counted and recorded separately. 
The results of assay were expressed as percentage change in cell density and 
viability to that of the control. The antiutumor effect was expressed as percentage of 
inhibition relative to control. Cell density and viability were calculated by the 
following equations: 
cell density (cell/ml) = cell 了 ber ^ ^ x i o ' cell/ml 
. , 船 number of viable cells 衝 viability (0/0) = X100% 
number of total cells 
Percentage of inhibition (%) was calculated as the following equation: 
Average cell density or viability in treatment group 
/ ( 1 - — ) x 100% 
^ J Average cell density or viability in control group 
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3.3.3.2 MTT assay method 
The in vitro antitumor effect against adhesive cancer cell lines HepG2 and 
MCF-7 were revealed by MTT assay method. This method is a quantitative 
colorimetric method for accessing cell growth and survival. MTT assay method is 
based on the ability of mitochondrial dehydrogenases in viable cells to convert soluble 
yellow tetrazolium salt (MTT) to dark blue formazan product. Since the number of 
viable cells is proportional to the amount of formazan product, cell growth and 
survival can be determined by measuring the color intensity of formazan product 
(Cochet etal., 1998). 
Stock samples were prepared as in Trypan blue exclusion method and diluted by 
corresponding medium to 2-fold higher concentration of the desired final 
concentration. 100 jjl/well of 5 x 1 s e l e c t e d tumor cells/ml medium were seeded into 
a sterile 96-well flat bottom tissue microplate (IWAKI, Japan) and mixed with 100 |a.l 
sample/well. Final DMSO concentration was kept at 0.5% (v/v) for water insoluble 
sample in each well. Wells with 100 0.5% DMSO in medium (water insoluble 
sample) or PBS instead of sample were used as control. Each concentration was 
performed in triplicate. The culture plate was incubated at fully humidified 
atmosphere with 37�C，5% CO2 and 95% room air for 72 h. 
/ 
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After 72 h, 20 freshly prepared MTT (3-(4,5-dimethylthiazol-2-yl)-2,5, 
diphenyl tetrazolium bromide) (Sigma) in 5 mg/ml filtered PBS was added into each 
well and incubated at 37°C, 5% CO2 for 5 h. Then the medium was removed and 150 
1^1 of acid isopropanol was added to each well. After pipette vigorously to dissolve the 
dark blue crystals, the absorbance was determined by microplate reader 
(SPECTRAmax 250) at 570 nm wavelength (Cochet et al, 1998). 
The proliferation of cells was expressed as average value of absorbance. And the 
antitumor activity was expressed as percentage of inhibition of sample treated group to 
control group by the following equation: 
Average O.D. 570 nm in treatment group 
( 1 — ) X 100% 
Average O.D. 570 nm in control group 
3.3.3.3 Determination of I C 5 0 
The I C 5 0 was determined. Selected cell lines were incubated with sample in a 
multiple doses. I C 5 0 was determined as the concentration that exerts 50% inhibition on 
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3.3.4 Cytotoxicity assay on normal cell lines 
The cytotoxicity of samples on normal cell lines were determined by evaluating 
the cell density of sample treated Vero and L-02 cell lines. The change in cell density 
was determined by MTT assay method. In brief, Vero or L-02 cells were incubated 
with samples at desired final concentration for 72 h. The detailed procedures were 
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3.4 In vivo Assay 
3.4.1 Animals 
Seven to eight-week-old male Balb/c mice weighing between 20 and 25 g were 
obtained from the Laboratory Animal Service Center of CUHK. They were kept in the 
animal house of the Biology Department of CUHK. The environment was maintained 
at 21 土 2°C with 12 h light/12 h dark cycle and mice were fed with normal mouse chow 
and tape water ad libitum. They were acclimatized for at least one week in these 
environment before used in the maintenance of cell line or for antitumor assay. 
3.4.2 Maintenance of Sarcoma 180 cell line 
Sarcoma 180 cells were used for the in vivo antitumor assay. Sarcoma 180 was 
maintained in the peritoneal cavity of male Balb/c mice as ascite tumor and weekly 
passage was performed. 
The ascitic fluid with Sarcoma 180 ascite tumor in the abdominal of male Balb/c 
mouse was collected after sacrificed by cervical dislocation. The cells were washed 
twice with 0.45% PBS by the aid of centrifuge (514 g for 5 min) (Beckman, Allegra丁M 
6R centrifuge). The cell pellet was dissolved and diluted to 2.5 x lO? living cells/ml in 
sterile PBS with the aid of 0.4% Trypan blue and hemocytometer. 0.2 ml (5 x 10^ 
J 
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living cells) cell suspension was intraperitoneally injected into the abdominal cavity of 
Balb/c mice and kept for seven days. Two mice were injected each time. 
3.4.3 Tumor inoculation 
2.5 X 10^ living cells/ml Sarcoma 180 cell suspension was prepared as in Section 
3.3.2. Male Balb/c mice anaesthetized by diethyl ether were subcutaneously 
inoculated with 0.2 ml cell suspension into the back (Day 0). Three days were allowed 
for solid tumor formation. At Day 3 (72 h after tumor inoculation), mice were 
examined carefully by hand, only mice with solid tumor formed were selected. Then 
they were randomly grouped into 8 per group and caged separately for the use in the 
experiment. 
3.4.4 Preparation of samples 
WT4-4 was dissolved in 5% DMSO in sterile PBS at a 2 mg/ml stock solution 
and dilute to 0.08,0.16, 0.32, 0.64 mg/ml by 5% DMSO respectively and stored at 4 � C 
until use. 
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3.4.5 In vivo antitumor assay 
3.4.5.1 Antitumor effect of WT4-4 on Sarcoma 180 solid tumor 
At Day 3, after tumor formation oheok, WT4-4 at iho clo§e of 0.4，0.8，l.o, 5.2 
mg/kg body weight were intraperitoneal (i.p.) injected into corresponding groups of 
mice once per day for ten consecutive days. Injection of 5% DMSO in sterile PBS 
instead of sample was performed on the control group. 
At Day 21 (9 days after the end of i.p. injection of sample dosage), the mice were 
sacrificed by cervical dislocation and the body weight of each mouse was determined. 
Then their tumors were excised and weighed. 
The average tumor weight of each group was determined and effect of WT4-4 on 
Sarcoma 180 solid tumor was expressed as percentage of tumor inhibition compared to 
control. It is calculated by the following equation: 
Percentage Average tumor weight of treatment group 
of = 1 X 100% 
Tumor inhibition (%) Average tumor weight of control group 
3.4.5.2 Effect of 5% DMSO in sterile PBS 
Since WT4-4 could not be dissolved in PBS, it was dissolved in 5% DMSO in 
sterile PBS. In order to determine if the solvent had any effect on Sarcoma 180 solid 
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tumor, tumor size of mice group received i.p. injection of 5% DMSO in sterile PBS 
was compared to control group received sterile PBS. 
3.4.6 Body weight change 
In order to investigate the side effect of WT4-4, change in body weight was used 
as the parameter to access the side effect. Body weight of each mouse before sample 
injection at Day 3 and before sacrificed at Day 21 was weighed. Average change in 
body weight was calculated. The change in treatment group was compared to the 
group without tumor inoculation and treatment. 
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Table 3.1 Table of schedule for in vivo antitumor assay. 
Day Experiment to carry out 
0 Tumor inoculation 
Tumor check and random grouping of mice 
3 Body weight determination 
First i.p. injection of WT4-4 
4-12 Daily consecutive i.p. injection of WT4-4 
End of experiment 
Sacrifice of the mice 
21 
Body weight determination 
Tumor excision and weighing 
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3.5 DNA Agarose Gel Electrophoresis 
DNA fragmentation of cells serves as an apoptotic marker and could be accessed 
by DNA extraction and gel electrophoresis. HL-60, K-562 and S-180 was respectively 
incubated with WT4-4 for 72 h as described in Section 3.2.3.1 at the corresponding 
I C 2 5 , I C 5 0 and I C 7 5 concentrations. Cells treated with 1 |iM camptothecin (Sigma) for 4 
h instead of WT4-4 served as positive control. I C 2 5 , I C 5 0 and I C 7 5 was determined as 
the concentration of WT4-4 that could exert 25%, 50% and 75% inhibition on cell 
density to that of control after 72 h incubation. 
After 72 h incubation, 2x10^ cells were harvested with the aid ofhemocytometer 
and washed twice with 5 ml PBS by centrifugation at 800 g for 5 min. The cell pellet 
was resuspended in 200 i^l ice-cold PBS. After that, 5 ml 70% ethanol at -20�C was 
added and kept at -20°C overnight to fix the cells. 
The fixed cells were centrifuged at 800 g for 5 min to remove the ethanol and 1 ml 
PBS was added to wash the cells. Then it was transferred to 1.5 ml eppendorf tube. The 
supernatant was removed completely after centrifugation at 800 g for 5 min. Then, the 
cell pellet was resuspended in 40 \i\ phosphate-citrate buffer (8 parts O.IM citric acid 
with 192 parts 0.2M Na2HP04, pH 7.8) and kept for 60 min at room temperature. After 
that, it was centrifuged at 1000 g for 5 min, the supernatant was transferred to a new 
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1.5 ml eppendorf tube and concentrated by SpeedVac concentrator (Savant Speed 
Vac® SC 110) for 15 min. It was followed by adding 3 [i\ Nonident NP-40 (0.25%) 
and 3 proteinase K (1 mg/ml) (Amersham), and incubated for 30 min at 3 7 � C (Lee 
et al, 2002). 
DNA content of different samples was measured by BioPhotometer 
(Eppendorf), and same amount of DNA was used for DNA agarose gel electrophoresis. 
1 [i\ loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF and 30% 
glycerol) was added to each 5 DNA extract, which was loaded into horizontal 0.8% 
agarose gel (FMC BioProducts) in 0.5X TBE buffer (BCH Medical Supplies Co.). The 
agarose gel was run at 13 V for 17 h. The gel was stained with 0.625 mg/ml ethidium 
bromide (1 drop per 50 ml gel) and photographed by UV illuminator (Bio-Rad Gel 
Doc 1000). 
3.6 Statistical Analysis 
The results were presented as mean 土 standard deviation (S.D.) and analyzed by 
Student's t-test, only p-value less than 0.05 (p < 0.05) were considered as statistically 
significance. The IC25, IC50 and IC75 (the concentration of sample that exhibited 25%, 
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50% and 75% inhibition on cell density in relation to control respectively) in some 





4.1 Extraction and characterization of Wedelia trilobata (WT) 
4.1.1 Percentage of yield in extraction and fractionation of WT 
After hot water extraction, 190.43 g WTl was obtained from 2 kg fresh aerial 
parts of WT and 34.37 g WT4 was obtained after ethanol precipitation. About 
twenty percent of WTl was found to be WT4 (Table 4.1). 
After fractionation of 20 g WT4 on macroporous resin column, four fractions 
were collected, WT4-1, WT4-2, WT4-3 and WT4-4, and the total yield was 92.8%. 
Among this, WT4-1 was the largest fraction contributing nearly 80%, WT4-2 
about five percent while WT4-3 and WT4-4 contributing same amount, 4.40% 
respectively (Table 4.2). 
After further fractionation of 300 mg WT4-4 on silica gel column, four 
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fractions were collected, WT4-4 A, WT4-4 B, WT4-4 C and WT4-4 D. WT4-4 D 
was the largest fraction, contributing 35% of WT4-4; WT4-4 A was the second 
large fraction, about 22%; WT4-4 B and WT4-4 C were small fractions, with 
much lower percentage of yield (Table 4.3 a). 25 mg purified component (crystal) 
was collected out of 100 mg WT4-4 A (Table 4.3 b). 
4.1.2 HPLC chromatograms of WT fractions and the purified component (crystal) 
The four fractions obtained from WT4 by macroporous resin column 
fractionation were analyzed by HPLC and the chromatograms were shown in 
Figures 4.1 一 4.4. WT4-1 and WT4-2 each showed two peaks while WT4-3 
showed three peaks before retention time of 10 min. WT4-4 showed five peaks 
before retention time of 10 min and two distinct peaks between retention time of 
10 to 15 min (Fig. 4.1-4.4). 
After further fractionation of WT4-4 by silica gel column, the four eluted 
fractions were also analyzed by HPLC and the chromatograms were shown in 
Figures 4.5 — 4.9. WT4-4 A showed a distinct major peak at retention time 12.363 
min (Fig. 4.6). WT4-4 B showed two peaks (Fig. 4.7), WT4-4 C showed three 
peaks with largest peak at retention time 4.28 min (Fig. 4.8) and WT4-4 D showed 
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three broad peaks which close to each other (Fig. 4.9). 
The chromatogram of the crystal isolated from WT4-4 A was shown in 
Figure 4.10. Retention time of the major peak of crystal was corresponding to the 
major peak in WT4-4 fraction (Fig. 4.11). 
4.1.3 Phytochemical groups of WT4-4 
WT4-4 showed positive results in chemical tests for lactones and courmarins, 
flavonoids, and terpenoids but negative results towards alkaloids, sterols and 
saponins, carbohydrates, and anthraquinone (Table 4.4). 
4.1.4 Results on X-ray crystallography of the isolated crystal from WT4-4 A 
The very pale yellow crystal isolated from WT4-4 A was found to be 
sesquiterpene lactone, crystal size 0.68 x 0.50 x 0.38 mm, which had empirical 
formula of C23H32O9 and formula weight 452.49. Molecular structure of the crystal 
was shown in Figure 4.12. 
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Table 4.1 Percentage of yield of WTl and WT4 from 2 kg fresh aerial parts of 
WT. 
Fraction Color Weight (g) Percentage of Yield (%) 
WTl Brown 190.43 9.25 ^  
WT4 Brown 34.37 1.72 “ 
18.05^ 
a o/o yield from fresh aerial parts of WT was calculated by: (weight of the fraction obtained 
/ 2 kg fresh aerial parts of WT) x 100% 
b % yield of WT4 from WTl was determined by: (weight of WT4 obtained / 190.43 g 
WTl) X 100% 
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Table 4.2 Recovery of WT fractions after application of 20 g WT4 to 
macroporous resin column. 
Fraction Color Weight (g) Percentage of Yield (%) 
WT4-1 Brown 15.72 78 .60� 
WT4-2 Pale yellow 1.08 5.40 “ 
WT4-3 Yellow 0.88 4 . 4 0 � 
WT4-4 Yellow 0.88 4 . 4 0 � 
Total -- 18.56 92.80 ^  
a % yield was calculated by: (weight of the fraction obtained / 20 g WT4) x 100% 
b recovery of total fractions after fractionation was calculated by: (total weight of all 
fractions / 20 g WT4) x 100% 
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Table 4.3 a Recovery of WT fractions after application of 300 g WT4-4 to Silica 
gel column. 
Fraction Color Weight (mg) Percentage of Yield (%) 
WT4-4 A Pale yellow 66.0 22.00^ 
WT4-4B Yellow 12.8 4.27 “ 
WT4-4 C Yellow 19.0 6.33^ 
WT4-4 D Brown 106.0 35.33 “ 
Total -- 203.8 67.93 ^ 
a o/o yield was determined by: (weight of the fraction obtained / 300 g WT4-4) x 100% 
b recovery of total fractions after fractionation was determined by : (total weight of all 
fractions / 300 g WT4-4) x 100% 
Table 4.3 b Percentage of yield of the crystal from 100 mg WT4-4 A. 
Fraction Color Weight (mg) Percentage of Yie ld� (%) 
Crystal Colorless 25 25 
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Figure 4.1 The HPLC chromatogram of WT4-1. 
WT4-1 was dissolved in methanol:water (40:60，v/v), determined by CI8 column, 
detected at 210 nm with mobile phase 0.1% acetic acid:methanol (40:60，v/v), temperature 
at 30°C and flow rate was set at 0.8 ml/min. 
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Figure 4.2 The HPLC chromatogram of WT4-2. 
WT4-2 was dissolved in methanol:water (80:20, v/v), determined by CI8 column, 
detected at 210 nm with mobile phase 0.1% acetic acid:methanol (40:60，v/v), temperature 
at 30°C and flow rate was set at 0.8 ml/min. 
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Figure 4.3 The HPLC chromatogram of WT4-3. 
WT4-3 was dissolved in methanol, determined by CI8 column, detected at 210 nm with 
mobile phase 0.1% acetic acid:methanol (40:60，v/v), temperature at 30°C and flow rate 
was set at 0.8 ml/min. 
84 
Results 
亡A … N 
恥 I 
\J i 
\ 八 \ - 丨 
\ \ J \ i �i i i 
J — 
0- 7 —--— 
” ‘ “ ‘ ‘ ~ ~ 1 1 1 “一 r — , 1 r — n ~ i | r - 丁 , “ 「 一 , , ~ r , ~ | . ~ r - ~ , ~ , , “ - r — r ‘ - " • , , | r — T , “ r - 「 - r — i ( 
Q 5 L5 10 15 17^  20 
Figure 4.4 The HPLC chromatogram of WT4-4. 
WT4-4 was dissolved in methanol, determined by CI 8 column, detected at 210 nm 'with 
mobile phase 0.1% acetic acid:methanol (40:60, v/v), temperature at 30°C and flow rate 
was set at 0.8 ml/min. 
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Figure 4.5 The HPLC chromatogram of the solvent methanol:chloroform (60:40， 
v/v) at flow rate 0.8 ml/min. 
Methanolxhloroform (60:40，v/v) was used to dissolve WT4-4 A and WT4-4 B, it's 
chromatogram was determined by CI8 column, detected at 210 nm with mobile phase 
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Figure 4.6 The HPLC chromatogram of WT4-4 A at flow rate 0.8 ml/min. 
WT4-4 A was dissolved in methanolxhloroform (60:40, v/v), determined by CI8 column, 
detected at 210 nm with mobile phase 0.1% acetic acid:methanol (40:60’ v/v), temperature 
at 30°C and flow rate was set at 0.8 ml/min. 
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Figure 4.7 The HPLC chromatogram of WT4-4 B at flow rate 0.8 ml/min. 
WT4-4 B was dissolved in methanolxhloroform (60:40, v/v), determined by CI8 column, 
detected at 210 nm with mobile phase 0.1% acetic acid:methanol (40:60, v/v), temperature 
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Figure 4.8 The HPLC chromatogram of WT4-4 C at flow rate 0.8 ml/min. 
WT4-4 C was dissolved in methanol, determined by CI8 column, detected at 210 nm with 
mobile phase 0.1% acetic acid:methanol (40:60, v/v), temperature at 30�C and flow rate 
was set at 0.8 ml/min. 
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Figure 4.9 The HPLC chromatogram of WT4-4 D at flow rate 0.8 ml/min. 
WT4-4 D was dissolved in methanol, determined by CI8 column, detected at 210 nm with 
mobile phase 0.1% acetic acid:methanol (40:60, v/v), temperature at 30°C and flow rate 
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Figure 4.10 (a) The HPLC chromatogram of methanol:chloroform (60:40, v/v) 
and (b) the chromatogram of the crystal isolated from WT4-4 A at 
flow rate 0.5 ml/min. 
The crystal isolated from WT4-4 A was dissolved in methanolxhloroform (60:40’ v/v), 
determined by CI8 column, detected at 210 nm with mobile phase 0.1% acetic 
acid:methanol (40:60, v/v), temperature at 30°C and flow rate was set at 0.5 ml/min. 
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Figure 4.11 The HPLC chromatogram of WT4-4 A at flow rate 0.5 ml/min. 
WT4-4 A was dissolved in methanolxhloroform (60:40，v/v), determined by CI8 column, 
detected at 210 nm with mobile phase 0.1% acetic acid:methanol (40:60’ v/v), temperature 
at 30°C and flow rate was set at 0.5 ml/min. 
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Table 4.4 Results of chemical tests on phytochemical groups of WT4-4. 
Tested phytochemical groups Tests Results ‘ 
Alkaloids Mayer reagent . 
Dragendorff reagent . 
Wagner reagent . 
Lactones and coumarins Ferric hydroxamie acid reaction + 
Emersen reagent + 
Flavonoids Shinoda test + 
Aluminum chloride reagent + 
Sterols Liebermann-Buchard test _ 
Salkowski reaction . 
Saponins Foam test _ 
Carbohydrates Molisch reagent . 
Aniline acetate reaction . 
Terpenoids Vanillin reagent + 
Carr-price reagent + 
Anthraquinone Borntrager reaction . 
Magnesium acetate reagent _ 
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Figure 4.12 (a) Chemical structure of the crystal C 2 3 H 3 2 O 9 (sesquiterpene lactone) 
isolated from WT4-4 A and (b) the molecular structure showing the 
atom labeling scheme. The C and O atoms were drawn as 30% 
‘ thermal ellipsoids. 
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4.2 In vitro Antitumor Assay 
4.2.1 Effects o fDI l , DM1, TMl and WTl on suspension cancer cell line 
� The in vitro effects of crude water extracts from DI, DM, TM and WT on 
HL-60 and K-562 were evaluated by Trypan blue exclusion method. All the four 
samples inhibited the proliferation of HL-60 and K-562 in a dose-dependent 
manner but only WTl, DIl and TMl showed statistically significant inhibition. 
WTl gave the most promising results in both cell lines, which significantly 
inhibited the proliferation of HL-60 and K-562 by 97.3% and 80.3% at 200 叩/ml 
respectively. WTl reduced the viability of HL-60 by 93.2% at 200 ^ig/ml but no 
significant effect on viability of K-562 was observed. Although both DIl and TMl 
significantly inhibited the proliferation of HL-60, only TMl significantly inhibited 
the viability at 200 |ig/ml by 10.6% (Fig. 4.13 and 4.14). 
4.2.2 Effects of WT fractions and the purified component (crystal) on suspension 
cell lines 
The effects were investigated by Trypan blue exclusion method. According to 
Figures 4.15 and 4.16，the water extract of WT (WTl) exhibited much stronger 
inhibition on proliferation and viability on both HL-60 and K-562 than the base 
(lo/o NaOH) extract (WT2), but both fractions did not significantly affect the 
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viability of K-562. WT2 did not show any significant effect on proliferation or 
viability of K-562. 
The ethanol supernatant fraction, WT4, exhibited much stronger inhibitory 
effect on proliferation and viability of HL-60 than the ethanol precipitated fraction 
WT7. At 200 |Lig/ml WT4 could significantly inhibit the proliferation of HL-60 by 
95.4% but the inhibition rate was only 21.4% for WT7. WT4 could significantly 
inhibit the viability of HL-60 by 83.8% but WT7 could not show any significant 
change (Fig. 4.17). As shown in Figure 4.18 WT4 significantly inhibited the 
proliferation of K-562 by 90.7% at 200 |Lig/ml but no significant change in cell 
viability was observed. WT7 could neither inhibit the proliferation nor viability of 
K-562 (Fig. 4.18). 
The effects of the four fractions, WT4-1, WT4-2, WT4-3 and WT4-4, 
obtained from WT4 after macroporous resin column fractionation on HL-60, 
K-562 and S-180 were demonstrated in Figures 4.19 - 4.21. WT4-4 was the most 
effective fraction to inhibit the proliferation and viability of all the three cell lines. 
It significantly inhibited the proliferation of HL-60, K-562 and S-180 by 96.1%, 
96.5% and 96.3% respectively at 100 ^g/ml and the viability by 100% for all cell 
lines at 100 呢/ml. WT4-3 was the second most effective fraction, followed by 
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WT4-2. At 200 |Lig/ml WT4-3 and WT4-2 significantly inhibited the proliferation 
of HL-60 by 74.5% and 48.6%; K-562 by 65.2% and 38.1%; and S-180 by 23.2% 
and 27.4% respectively. WT4-1 could only significantly inhibit the proliferation of 
S-180 at 200 昭/ml by 17.3%. WT4-1, WT4-2 and WT4-3 could not affect the 
viability of all the cell lines. The IC50 of WT4-4 on proliferation on HL-60, K-562 
and S-180 were determined to be 4 |ig/ml, 6.5 ^ig/ml and 8 ^ig/ml respectively (Fig. 
4.22-4.24). 
The effects of the four fractions, WT4-4 A, WT4-4 B, WT4-4 C and WT4-4 
D，fractionated from WT4-4 after silica gel column chromatography on HL-60, 
K-562 and S-180 were investigated. At the tested doses, WT4-4 A was the only 
antitumor fraction effective on all the cell lines. All the other fractions could not 
inhibit the proliferation or viability on all the tested cell lines. WT4-4 A could 
significantly inhibit the proliferation of all three cell lines even at the lowest tested 
dose 2 fig/ml. It could significantly inhibit the proliferation of HL-60, K-562 and 
S-180 by 94.3%, 96.2% and 96.7%; and the viability by 97%, 22.2% and 29% 
respectively at 8 |Lig/ml. The IC50 on proliferation of HL-60, K-562 and S-180 were 
determined to be 3 |Lig/ml, 3.4 )ag/ml and 2.8 |Lig/ml respectively (Fig. 4.25 - 4.30). 
The effects of the crystal isolated from WT4-4 A on HL-60 were investigated. 
97 
Results 
The lowest tested concentration of WT4-4 A that exhibited significant inhibition 
on proliferation of HL-60 was determined to be 1.56 昭/ml with 28.9% inhibition. 
The viability of HL-60 was significantly inhibited by 100% at 6.25 ^g/m\ (Fig. 
4.31). The IC50 on proliferation of HL-60 was determined to be 2.2 [ig/m\ (Fig. 
4.32). 
4.2.3 Effects of WT fractions on adhesive cancer cell lines 
The effects of the four fractions, WT4-1, WT4-2, WT4-3 and WT4-4, 
obtained from WT4 after macroporous resin column fractionation on MCF-7 and 
HepG2 were determined by MTT assay method. Only WT4-4 could significantly 
inhibit the proliferation of MCF-7 in the experiment. It significantly inhibited the 
proliferation by 77.4% at 50 ^ig/ml (Fig. 4.33) with the IC50 equal to 36 ^ig/ml (Fig. 
4.34). Besides, WT4-4 significantly inhibited the proliferation ofHepG2 by 51.4% 
at 25 ^ig/ml and up to 100% at 100 |ig/ml (Fig. 4.35), with the IC50 equal to 24 
|Lig/ml (Fig. 4.36). 
4.2.4 Effects of WT4-4 on normal cell lines 
The effects of WT4-4 on Vero and L-02 were investigated by MTT assay 
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method. WT4-4 did not show significant cytotoxicity on L-02 up to 50 |ig/ml (Fig. 
4.37) and on Vero up to 6.25 |Lig/ml (Fig. 4.38). However, WT4-4 at the 
concentration of 12.5 ^ig/ml or higher exhibited significant cytotoxicity on Vero 
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Figure 4.26 IC50 of WT4-4 A on HL-60 cells 
The effect of WT4-4 A on HL-60 was evaluated by Trypan blue exclusion method after 72 h 
incubation. The result was expressed as cell density in % of control to determine the IC50 of 
proliferation on HL-60 cells. Cell density in % of control was calculated by: (average cell 
density of treatment group / average cell density of control group) x 100%. 
















































































































































































































































































































































































































































































































































































^ 80 - 丄 
I 7 � _ \ 
^ 60 \ 
.S \ IC50 = 3.4 |Lig/ml 
会 50 \ 
00 \ 
g \ T ** 
40 - \ 
% S v ^ 
30 -
20 - ^ ^ ^ ^ ^ 
( I - .--. --- -1- - - - - — J „ -- I * ^ L 
U - - ‘ - - .L. 1 I ^ 
0 1 2 3 4 5 6 7 8 9 
concentration (ug/ml) 
Figure 4.28 IC50 of WT4-4 A on K-562 cells 
The effect of WT4-4 A on K-562 was evaluated by Trypan blue exclusion method after 72 h 
incubation. The result was expressed as cell density in % of control to determine the IC50 of 
W丁4-4 A on K-562 cells. Cell density in % of control was calculated by: (average cell 
density of treatment group / average cell density of control group) x 100%. 
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Figure 4.30 IC50 ofWT4-4 A on S-180 cells 
The effect of WT4-4 A on S-180 was evaluated by Trypan blue exclusion method after 72 h 
incubation. The result was expressed as cell density in % of control to determine the IC50 of 
WT4-4 A on S-180 cells. Cell density in % of control was calculated by: (average cell 
density of treatment group / average cell density of control group) x 100%. 
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Figure 4.32 IC50 of the crystal isolated from WT4-4 A on HL-60 cells 
The effect of WT4-4 A on HL-60 was evaluated by Tiypan blue exclusion method after 72 h 
incubation. The result was expressed as cell density in % of control to determine the IC50 of 
the crystal isolated from WT4-4 A on HL-60 cells. Cell density in % of control was 
calculated by: (average cell density of treatment group / average cell density of control group) 
X 100%. 
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Figure 4.33 Effect of the four fractions from WT4 on proliferation of MCF-7 cells. 
The effects of the four fractions obtained after macroporous resin column fractionation on 
MCF-7 were evaluated by MTT assay method after 72 h incubation. The results were 
expressed as mean of absorbance at O.D. 570 nm ± S.D. of three replicates. 
十 showed the % of inhibition on proliferation of MCF-7. 
* P<0.05 (t-test); ** p<0.01 (t-test). 
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Figure 4.34 I C 5 0 of the WT4-4 on proliferation ofMCF-7 cells. 
The effects of the four fractions obtained after macroporous resin column fractionation on 
MCF-7 were evaluated by MTT assay method after 72 h incubation. The results were 
expressed as mean of absorbance at O.D. 570 nm in % of control of three replicates. The 
O.D. 570 in % of control was calculated by: (average absorbance of treatment group / 
average absorbance of control group) x 100% 
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Figure 4.35 Effect of the four fractions from WT4 on proliferation of HepG2 cells. 
The effects of the four fractions obtained after macroporous resin column fractionation on 
HepG2 were evaluated by MTT assay method after 72 h incubation. The results were 
expressed as mean of absorbance at O.D. 570 nm 土 S.D. of three replicates. 
十 showed the % of inhibition on proliferation of HepG2. 
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Figure 4.36 I C 5 0 of the WT4-4 on proliferation of HepG2 cells. 
The effects of the four fractions obtained after macroporous resin column fractionation on 
HepG2 were evaluated by MTT assay method after 72 h incubation. The results were 
expressed as mean of absorbance at O.D. 570 nm in % of control of three replicates. 
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Figure 4.37 Effect of WT4-4 on proliferation of L-02 cells. 
The cytotoxicity effect of WT4-4 on normal cell line L-02 cells was determined by MTT 
assay method after 72 h incubation. The results were expressed as mean of absorbance at 
O.D. 570 nm 土 S.D. of three replicates. 
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Figure 4.38 Effect ofWT4-4 on proliferation of Vero cells. 
The cytotoxicity effect of WT4-4 on normal cell line Vero cells was determined by MTT 
assay method after 72 h incubation. The results were expressed as mean of absorbance at 
O.D. 570 nm 士 S.D. of three replicates. 
* P<0.05 (t-test); ** pO.Ol (t-test) 
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4.3 In vivo Antitumor Effect of WT4-4 
WT4-4 was dissolved in 5% DMSO in the in vivo assay, and the effect of this 
solvent on Sarcoma 180 growth in Balb/c mice was not significantly different from 
that of PBS (Fig. 4.39). 
WT4-4 could significantly inhibit the growth of Sarcoma-180 tumor in Balb/c 
mice from 0.8 mg/kg by i.p. injection in a dose-dependent manner. It inhibited the 
growth of Sarcoma 180 by 62.79% at the dose of 3.2 mg/kg (Fig. 4.40). 
WT4-4 at the dose of 0.4 mg/kg, 0.8 mg/kg and 1.6 mg/kg did not 
significantly affect the body weight in Sarcoma 180-bearing mice from control 
group. At 3.2 mg/kg, WT4-4 significantly increased the body weight by 5.26% 
when compared to control group but there was no significant different when 




Treatment Average tumor weight (g) 土 S.D. ‘ % change in tumor weight ^  
PBS 0.45 ±0.16 -






PBS 5% DMSO 
Figure 4.39 Effects of PBS and 5% DMSO on Sarcoma 180 solid tumor. 
5 X 106 Sarcoma 180 cells were subcutaneously injected into the back of male Balb/c mice. 
Three days later, PBS or 5% DMSO were daily i.p. injected into the tumor-bearing mice for 
10 consecutive days. 
The effects of PBS and 5% DMSO on Sarcoma 180 solid tumor in male Balb/c mice were 
expressed as average tumor weight (g) 土 S.D. (n = 7). Statistically significant value was 
marked with * and ** for p < 0.05 and p < 0.01 respectively. 
十 showed the average tumor weight of PBS or 5% DMSO treated tumor-bearing mice and 
the % change of 5% DMSO treatment to PBS treatment. 
a The tumor was excised and weighed 9 days after the 10 consecutive days injection, 
b % change was calculated by: (average tumor weight of treatment group - control group) / 
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DMSO (Control) ^ 0.86 ±0.31 “ 
WT4-4 0 . 4 mg/kg 0 . 6 0 士 0 . 2 5 -30 .23 
0.8 mg/kg 0.57 ±0.24 -33.72 * 
1.6 mg/kg 0 . 4 8 土 0 . 1 9 - 4 4 . 1 9 
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Figure 4.40 Effects of WT4-4 on Sarcoma 180 solid tumor. 
5 X 106 Sarcoma 180 cells in 0.2 ml were subcutaneously injected into the back of male 
Balb/c mice. Three days later, WT4-4 in different concentrations was daily i.p. injected into 
the tumor-bearing mice for 10 consecutive days. 
The effects on Sarcoma 180 solid tumor in male Balb/c mice were expressed as average 
tumor weight (g) ± S.D. (n = 8). Statistically significant values were marked with * and ** 
for p < 0.05 and p < 0.01 respectively. 
t showed the average tumor weight of WT4-4 treated groups and the % change of treatment 
groups to control groups (5% DMSO). 
a The tumor was excised and weighed 9 days after the 10 consecutive days injection, 
b % of inhibition was calculated by: (average tumor weight of treatment group 一 control 
group) / control group x 100% 
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Table 4.5 Effect of WT4-4 on body weight change of Sarcoma 180 bearing mice. 
Group Average body weight (g) 土 S.D. % change in body 
Initial (I) Final (F) weight ^  
Control (5% DMSO) 23.42 士 1.79 24.86 土 1.54 +2.48 
0.4 mg/kg WT4-4 23.18 ± 1.10 24.77±1.03 +4.27 
0 . 8 mg/kg WT4-4 2 2 . 9 6 士 1 .53 2 4 . 2 7 土 1 . 6 9 + 3 . 2 2 
1.6 mg/kg WT4-4 22.40 ± 0.68 23.84 ±0.71 +4.29 
3 . 2 mg/kg WT4-4 2 3 . 0 1 土 1 . 8 0 2 4 . 5 4 土 1 . 7 8 + 5 . 2 6 • 
Weight control 24.55 土 1.64 25.63 ±1.18 +4.40 
5 X 106 Sarcoma 180 cells in 0.2 ml were subcutaneously injected into the back of male 
Balb/c mice. Three days later, WT4-4 in at the dose of 0.4 mg/kg, 0.8 mg/kg, 1.6 mg/kg, 3.2 
mg/kg or 5% DMSO were daily i.p. injected into tumor-bearing mice for 10 consecutive 
days. Mice without tumor inoculation or treatment were used as weight control group. Initial 
weight (I) of mice was weighed before the experiment and final weight (F) of mice was 
weighed at the end of the experiment before tumor excision. 
The effect of WT4-4 on Sarcoma 180 tumor bearing mice was expressed as average body 
weight (g) 土 S.D. (n=8). 
a % change in body weight was calculated by: (F — tumor weight - I) /1 x 100% Statistically 
significant difference in % change in body weight of treatment group to control (5% DMSO) 
group was marked with * for p < 0.05. 
Statistically significant difference in % change in body weight of treatment group to weight 
control group was marked with # for p < 0.05. 
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4.4 Results of DNA Agarose Gel Electrophoresis 
DNA extracted from WT4-4-treated HL-60, K-562 and S-180 respectively 
after 72 h incubation were run on agarose gel electrophoresis. The results were 
presented in Figure 4.41. When compared to the positive control, WT4-4 did not 
cause DNA laddering on gel electrophoresis in HL-60, K-562 or S-180 at the 
corresponding IC25, IC50 and IC75. 
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HL-60 K-562 S-180 
Figure 4.41 DNA agarose gel photo of WT4-4 treated HL-60, K-562 and S-180. 
HL-60, K-562 and S-180 were incubated with WT at the corresponding IC25, IC50 and IC 
75 for three days. Their DNA were extracted and subjected to DNA agarose gel 
electrophoresis on 0.8% gel. Positive control (+ve) was DNA from cells treated with l^ iM 
camptothecin for 4 h. Control (Ctl) was DNA from cells that without any treatment. IC25, 
ICso and IC 75 were the concentrations of WT4-4 that induced 25%, 50% and 75% 





5.1 Characterization of Antitumor Fraction and Compound of Wedelia trilobata 
(WT) 
Active fractions from WT were extracted by hot water extraction, ethanol 
precipitation and further fractionated by bioactivity-guided purification. According to 
Figures 4.17 - 4.18，the active fraction from WT water extract (WTl) was found to 
be the small molecular fraction in the supernatant (WT4), which exhibited antitumor 
effect on both HL-60 and K-562 leukemia cells. 
Since WT4 was derived from water extraction at the beginning, in order to 
purify the active fraction, macroporous resin column that is usually used to separate 
samples with stronger polarity was employed to briefly fractionate WT4. Four 
solutions with decreasing polarity, i.e. water, 15% ethanol, 30% ethanol and 60% 
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ethanol, were used in sequence to fractionate WT4, which then gave rise to WT4-1, 
WT4-2’ WT4-3 and WT4-4 fractions respectively. WT4-4, the less polar fraction 
eluted by 60% ethanol, was the most active fraction against the proliferation of 
HL-60，K-562, S-180, MCF-7 and HepG2 cell lines (Fig. 4.19 - 4.21，Fig. 4.33, Fig. 
4.35). According to the HPLC chromatograms (Fig. 4.1 - 4.4)，WT4-4 contained a 
distinct large peak at retention time of 12.383 min (17%) that was not found in the 
other fractions at flow rate 0.8 ml/min. The chemical tests of phytochemical groups 
on WT4-4 (Table 4.4) showed that there were lactones and coumarins, flavonoids 
and terpenoids, but no alkaloids, sterols, saponins, carbohydrates, polyglucose nor 
anthraquinone. This implied that the active ingredients of WT4-4 might be lactones, 
coumarins, flavonoids or terpenoids. These compounds can also be found in other 
Compositae plants. Some showed bioactivities, for example, sesquiterpene lactones 
from Ratibida mexicana exhibited antitumor activity against solid tumor cell lines 
(Calera et al, 1995); diterpene lactones were found in Wedelia regis (Bohlmann et 
a!., l 9 8 4 b) ; coumarin with antitumor activity was found in Saussurea eopygmaea 
(Zong et al., 1994); a flavonoid, silymarin, from milk thistle exhibited 
antihepatotoxic effect, antioxidative activity and against skin tumor promotion 
(Chatterjee et al., 1999); diterpenoid, triterpene and flavonoids were found in 
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Wedelia asperrima (Calanasan and Macleod, 1997); sesquiterpenoids from Achillea 
millefolium exhibited in vivo antitumor activity against mouse P-388 leukemia cells 
(Tozyo et al, 1994); and terpenoids were found in Wedelia chinensis (Huang et al., 
1997). 
Although WT4-4 contained a distinct peak in HPLC at retention time 12.383 
min，it also contained some broad and overlapping peaks before retention time of 10 
min. WT4-4 was thus further purified by silica gel column in order to find out the 
active ingredients contributed to the antitumor effect. Among the four eluted 
fractions, the first one (WT4-4 A) with lower polarity, obtained by elution of first 
100 ml chloroform : ethyl acetate : n-hexane : methanol ( 3 : 1 : 1 : 0.5) was found to 
be the active fraction (Fig. 4.25, 4.27, 4.29). The HPLC chromatogram of this 
fraction (Fig. 4.6) showed a major distinct peak at retention time of 12.363 min (39%) 
that was not found in the other three less active fractions. Besides, the retention time 
of this peak was consistent with the unique peak in WT4-4 with retention time 
(12.383 min). Therefore this compound was believed to be a marker peak of the 
antitumor effect in WT. Although there were still some minor peaks with retention 
time before 10 min in WT4-4 A, the amount was much smaller than that in WT4-4, 
that means WT4-4 A was more homogenous fraction and proportion of the marker 
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peak was higher. 
After the fraction WT4-4 A was concentrated and stood overnight, crystals were 
formed. This compound could exhibit antitumor effect on HL-60 (Fig. 4.31). From 
the HPLC chromatogram of the crystal at flow rate 0.5 ml/min (Fig. 4.10)，there was 
only one major peak at retention time 19.505 min (83%) and a small peak at 
retention time of 27.432 min. The retention time of the major peak of the crystal was 
consistent with the major maker peak in WT4-4 A but in higher proportion (Fig. 4.11) 
at flow rate 0.5 ml/min (retention time at 19.847 min). Since the major peak 
contributed over 80% so the antitumor activity was properly due to this compound. 
According to the X-ray crystallography results of the crystal (Fig. 4.12), the 
empirical formula was determined to be C23H32O9, with one lactone ring and the 
chemical structure showed this antitumor compound was sesquiterpene lactone. The 
lactone and terpenoid structures of this compound were consistent with the chemical 
tests for phytochemical groups of WT4-4. Isolation of sesquiterpene lactones from 
other Compositae species had also been reported. For examples, several 
sesquiterpene lactones have been isolated from Artemisia annua (Beekman, et aL, 
1998)，Podachaenium eminens (Castro et aL, 2000)，Arnica montana. Arnica 
chamissonis (Woerdenbag et al., 1994) and Neurolaena lobata (Francois et al, 1996). 
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Many of these sesquiterpene lactones possessed antitumor activities. 
Sesquiterpene lactones with same empirical formula of the crystal obtained in 
this project were also reported in other publications, and these compounds were 
found in Wedelia species, including the aerial parts of Wedelia trilobata (Bohlmann 
et a!., 1981), the aerial parts of Wedelia prostrata (Ragasa and Padolina, 1993) and 
also leaves of Wedelia prostrata (Farag et al., 1996). However, only the 
sesquiterpene lactone reported by Farag et al (1996) was same as the crystal in this 
project. The other two sesquiterpene lactones reported by Bohlmann et al (1981) and 
Ragasa and Padolina (1993) were different from the sesquiterpene lactone isolated in 
this project in stereochemistry. 
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5.2 Antitumor Effects of WT Fractions and Purified Component (Crystal) 
5.2.1 In vitro assay 
In the screening of most prominent antitumor agents in Compositae among 
Dendranthema indicum (DI), Dendranthema morifolium (DM), Taraxacum 
mongolicum (TM) and Wedelia trilobata (WT), WTl was found to be the most 
effective water extract on both HL-60 and K-562 leukemia cells while DM1 did not 
affect the proliferation nor viability of both cell lines (Fig. 4.13，Fig. 4.14). For all 
the four selected Compositae species, HL-60 was more sensitive than K-562. 
Moreover, none of the water extracts could inhibit the viability of K-562. 
When comparing WTl and WT2, the antitumor activity of WTl was much 
stronger in both HL-60 and K-562 (Fig. 4.15, Fig. 4.16). WTl could exhibit 
significant inhibition (18.6%) on proliferation of HL-60 at the lowest dose of 50 
^ig/ml and 27.3% on K-562 at 100 ^g/ml. At 200 ^ig/ml, it could inhibit the 
proliferation of HL-60 and K-562 by 94.9% and 84.8% respectively. However, WT2 
could only inhibit the proliferation of HL-60 by 13.3% at 200 ^ig/ml. These implied 
that the antitumor effect of water extract of WT was more effective than that of the 




The ethanol supernatant (WT4) from WTl was found to be a stronger antitumor 
fraction than the ethanol precipitate (WT7) on both HL-60 and K-562 (Fig. 4.17，Fig. 
4.18). The lowest effective dose for both cell lines were same as WTl, but the 
percentage of inhibition on proliferation was higher, especially in HL-60 cells, 
increased from 18.6% to 28.1% at 50 i^g/ml. 
It was not surprised that the more pure fraction after resin column fractionation 
would have stronger inhibitory effect on the cancer lines. Among the four eluted 
fractions, WT4-1 was inactive to all the tested cell lines, except on S-180, with mild 
inhibitiory effect on proliferation at high dose. Although all the other three fractions 
exhibited antitumor effect on the suspension cell lines HL-60, K-562 and S-180 in a 
dose-dependent manner, WT4-4 was the most prominent fraction and the percentage 
of inhibition on HL-60 and K-562 was much higher than that of WT4, which was 
obtained before column fractionation. The percentage of inhibition on proliferation 
of HL-60, K-562 and S-180 was 96.8%, 97% and 96.4% at 50 ^g/ml (Fig. 4.19 -
4.21). The antiproliferative effect of WT4-4 increased by 244% on HL-60 cells and 
8240/0 on K-562 cells when compared to WT4 at the dose of 50 ^g/ml The viability 
of WT4-4 on all these suspension cell lines reached 100% inhibition. The effect was 
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also much stronger in WT4-4 than that in WT4. 
When the tested concentration shifted to lower range in multiple from 0.78 
)ig/ml to 50 )ig/ml, the effect also showed in a dose dependent manner, the lowest 
statistically significant inhibition on proliferation of HL-60, K-562 and S-180 was 
found to be 0.78 ^ig/ml with 20.3% inhibition, 3.13 ^ig/ml with 10.5% inhibition and 
6.25 ^ig/ml with 34% inhibition respectively. The IC50 on HL-60, K-562 and S-180 
was determined to be 4 ^g/ml, 6.5 ^ig/ml and 8 ^ig/ml respectively (Fig. 4.22 — 4.24). 
These data further indicated the more purified fraction WT4-4 with higher 
percentage of the active ingredient and HL-60 was the most sensitive suspension cell 
line. 
The effects of the four fractions obtained from resin column fractionation on 
adhesive cell lines were similar to that in suspension cell line, WT4-1 was inactive to 
both MCF-7 and HepG2 while WT4-4 was the most effective antitumor fraction, but 
the effects were not as strong as in the suspension cell lines. The lowest effective 
dose was lower in MCF-7 (12.5 |Lig/ml) than HepG2 (25 ^g/ml). But the IC50 of 
HepG2 (24 ^ig/ml) was lower than MCF-7 (36 ^ig/ml). This difference may due to 
the difference in sensitivity of different cell lines to the active ingredient. WT4-2 and 
WT4-3 could inhibit the proliferation ofHepG2 in a dose dependent manner but in a 
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much lower percentage than WT4-4, both with the lowest significant dose at 100 
|Lig/ml (Fig. 4.33-4.36). 
Other than the antitumor effects, cytotoxicity on normal cells of antiutumor 
substance are also important, therefore the in vitro cytotoxicity of WT4-4 on L-02 
and Vero were determined. There was no cytotoxicity effect on normal human liver 
cell line, L-02, up to the highest tested dose, 50 |Lig/ml; and on normal monkey 
kidney cell line, Vero, up to 6.25 ^ig/ml (Fig. 4.37, Fig. 4.38). This data indicated that 
WT4-4 did not has cytotoxic effect on L-02 up to 64 times, 16 times, 8 times, 4 times 
and 2 times of the lowest significant antiproliferative dose of HL-60, K-562, S-180, 
MCF-7 and HepG2 respectively. When IC50 was considered, WT4-4 did not has 
cytotoxic effect on L-02 up to 12.5 times, 7.7 times, 6.25 times, 1.4 times and 2.1 
times of the IC50 of HL-60, K-562, S-180, MCF-7 and HepG2 respectively. When 
compared the antitumor effect of WT4-4 to the cytotoxic effect on Vero, WT4-4 did 
not has cytotoxic effect on Vero up to 8 times and 2 times of the lowest significant 
antiproliferative dose of HL-60 and K-562 respectively，and no cytotoxic effect was 
observed at the lowest significant antiproliferative dose of S-180. However, for 
MCF-7 and HepG2，there was cytotoxic effect on Vero cells at the statistically 
significant antiproliferative dose. The cytotoxicity results on normal cell lines 
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indicated that L-02 was more resistance to WT4-4 but Vero was more sensitive, this 
may due to the fact that difference cells with different sensitivity or due to the two 
cell lines come from different species, one from human (L-02) and the other from 
monkey (Vero). Besides, the effective doses of WT4-4 on all cell lines were not 
cytotoxic to the normal human cell line, L-02. 
After further purification ofWT4-4 by silica gel, WT4-4 A was found to be the 
only antitumor fraction which exhibited antiproliferative effects on HL-60, K-562 
and S-180, the effects were in dose dependent manner. As expected, this more 
purified fraction exhibited stronger antitumor effect on the three cell lines than 
WT4-4. The IC50 on proliferation of HL-60, K-562 and S-180 were 3 |ig/ml，3.4 
^ig/ml and 2.8 ^ig/ml (Fig. 4.25 - 4.30), decreased by 25%, 48% and 65% 
respectively when compared to WT4-4. The inhibition on viability was also 
increased. These results indicated that the active ingredient on WT4-4 had been 
further purified and increased in WT4-4 A by the silica gel column purification, the 
inactive ingredients were separated form WT4-4 A to the other three fractions. 
The crystal obtained from WT4-4 A was a more purified compound, and 
through X-ray crystallography, it was found to be an antitumor sesquiterpene lactone, 
with IC50 equal to 2.2 呢/ml on HL-60 cell proliferation (Fig. 4.32) which was 27% 
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lower than that of WT4-4 A. The proportion of the major peak of this crystal 
increased as purification proceeded from WT4-4 to the crystal finally obtained, and 
the antitumor effect also became stronger and stronger. Therefore, this sesquiterpene 
lactone (C23H32O9) is considered as the major antitumor compound account for the 
antitumor effect. 
Sesquiterpene lactones with same empirical formula with the crystal of this 
project but different stereochemistry were reported in the aerial parts of Wedelia 
—bata (Bohlmann et al, 1981) and in the leaves of Wedelia prostata (Ragasa and 
Padolina，1993). However，none of these publications mentioned about the antitumor 
activity. Sesquiterpene lactone same as the crystal of this project was obtained from 
the aerial parts of Wedelia prostata (Farag et a!.’ 1996) was reported to have no 
inhibitory effect on the growth of cervical cancer cell line, HeLa S3 cells. 
It is difficult to compare the antitumor activities of this sesquiterpene lactone to 
other antitumor sesquiterpene lactones because the cancer cell lines used may be 
different, the incubation time may also different, the assay method may be different, 
moreover, the percentage of purity of the sesquiterpene lactone in this project are not 
exactly known. All these factors would affect the antitumor activities when 
comparing different compounds. However, some datum can be used for reference. 
142 
“ Discussion 
Helenalin exhibited antitumor activity with IC50 0 . 1 ^g/ml on colon carcinoma 
HT-29，helenine, with IC50 7 ^ig/ml, the assay method was cell colony formation 
(Powis et aL, 1994). On human leukemia Jurkat T cells, by MTT assay method, 
helenalin with an IC50 6 pM (Dirsch et aL, 2001). On lymphocytic leukemia P388， 
cell growth assayed by Coulter counter, (11 S)-3-Oxoeudesmano-l3,6a-lactone 
exhibited 16% cell growth inhibitory ratio at 10 ^ig/ml and 
2a-Bromo-3-oxoeudesm-ll(12)-eno-13,6a-lactone exhibited 106% cell growth 
inhibitory ratio at 1 \xg/m\ (Ando et al, 1987). 
5.2.2 DNA agarose gel electrophoresis 
Since the viability of WT4-4 treated HL-60, K-562 and S-180 respectively 
decreased，they were subjected to DNA agarose gel electrophoresis to see whether 
the antitumor effect was mediated by apoptosis accompanying with DNA 
fragmentation. However, all the three WT4-4 treated cell lines at IC25, IC50 and I C 7 5 
did not show the DNA laddering pattern, which is a marker of apoptosis. These 
results indicated that the WT4-4 did not cause DNA fragmentation and was not likely 
to induce apoptosis in vitro. Nevertheless there was exception, although DNA 
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fragmentation is a hallmark of apoptosis but not all apoptotic cells were accompanied 
with DNA fragmentation. For examples, dietary polyunsatureated fatty acids, 
arachidonic acid and eicosapentaenoic acid, which induce apoptosis in HL-60 cells 
but DNA fragmentation was not induced (Chiu et al., 2000). 
5.2.3 In vivo assay 
Since WT4-4 exhibited antitumor effect in S-180 solid tumor cell lines, the in 
Wvo antitumor effect on Sarcoma 180 was investigated. According to the results, 
WT4-4 exhibited in vivo antitumor effect against Sarcoma 180 in Balb/c mice from 
the lowest dose of 0.8 mg/kg to 3.2 mg/kg in a dose dependent manner with 33.72% 
and 62.79% respectively (Fig. 4.40). This positive result was consist with another 
胸elia species，Wedelia chineses, the water extracts of this whole plant also 
exhibited in vivo antitumor effect in mice (江蘇新醫學院，1977). 
The in vivo side effect of WT4-4 was expressed as change in body weight. 
According to the results (Table 4.5), WT4-4 did not affect the body weight of 
tumor-bearing mice when compared to normal mice without tumor inoculation nor 
any treatment at all the tested doses. The body weight of tumor-bearing mice 
144 
“ Discussion 
received WT4-4 at 3.2 mg/kg even having significant increase in body weight when 
compared to the control tumor-bearing mice group which received 5% DMSO. These 
data indicated that WT4-4 did not confer in vivo side effect in body weight at those 
effective doses. 
According to the results from in vitro assay and in vivo assay, the sesquiterpene 
lactone isolated in this project exhibited promising antitumor activities, but for 
further development, specificity of antitumor activity should be investigated in more 
detailed because many but not all sesquiterpene lactones were reported with different 
degree of cytotoxicity or allergic effect in humans (Rodriguez et al., 1976). On the 
other hand, the solubility and effect of sesquiterpene lactones could be increased by 
chemical modification. A good example is arglabin-DMA, deriviative of 
sesquiterpene lactone arglabin with stonger antitumor activity and higher solubility, 
is registered as a compound with antitumor activity in the Republic of Kazakstan 
(Shaikenov et al, 2001). The sesquiterpene lactone isolated in this project is worthy 
for further development. 
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5.3 Further Study 
The antitumor effects of WT in vitro and in vivo have been studied in a great 
extent, but according to the results of DNA agarose gel electrophoresis, it only 
showed that WT4-4 did not cause DNA fragmentation on HL-60, K-562 and S-180, 
and the mechanism of the antitumor activity have not been fully illustrated. 
Therefore further study on the mechanism is needed in order to find out the pathway 
for the antitumor effect, for example, the change in cell cycle can be observed by 
DNA-PI flow cytometry, which can reveal whether the cells are arrested in any 
particular phase of cell cycle. Besides, bivariate annexin V/PI flow cytometry, which 
utilizes the characteristic of apoptotic cell other than DNA fragmentation, can reveal 
the change in membrane property of cells. In which, early apoptotic cells will be 
stained by annexin V (green) in the membrane due to the presence of 
phosphatidylserine (PS) but resist the penetration of propidium iodide (PI) (red). On 
the other hand, necrotic cells with ruptured cell membranes will be stained in both 
green and red. 
Moreover, increase in the level of Caspase-3 can also be observed in apoptotic 
cells. Caspase-3 is an effector caspase, which acts like an apoptotic executor, and 
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induces apoptosis once is activated by different apoptotic signal (Nunez et ah, 1998). 
Therefore, the occurrence of apoptosis can also be reflected by measuring the 
activation level of caspase-3, as commercially available kit can be used for the 
measurement of caspase-3 related protease activity. 
Furthermore, western blot and immunodetection of cellular proteins, like pRb 
and cyclin D can also be used to investigate any changes in these protein levels in the 
treated cells. In which, Rb is known as tumor supressor gene and cyclin D is related 
to pRb in controlling the passage through G1 phase. 
Other than hand, the cytotoxiciy of the isolated sesquiterpene lactone should 





In this project, antitumor fractions and compound from Wedelia trilobata were 
extracted and isolated by bioactivity-guided fractionation. Firstly, by hot water 
extraction (WTl) and the active fraction was found to be the small molecules in 
supernatant fraction after ethanol precipitation (WT4). Further purification was 
carried out by macroporous resin column Djoi. The fourth fraction WT4-4 with 
weaker polarity, was found to be the most effective one among the four eluted 
fractions. Lactones, coumarins, flavonoids and terpenoids were found in WT4-4 by 
phytochemical tests. After silica gel column fractionation of WT4-4, the most 
effective fraction was found to be the first fraction, WT4-4 A，with weaker polarity. 
After that, the more purified component sesquiterpene lactone with empirical 
formula C23H32O9 was isolated form WT4-4 A. The antitumor effects of the active 
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fractions were in dose-dependent manner. 
The in vitro antitumor effects increased as purification proceed. WTl could 
inhibit the proliferation of HL-60 by 18.6% at the lowest dose of 50 )ng/ml and 
K-562 by 27.3% at 100 |ag/mL WT4 could inhibit the proliferation of HL-60 by 
28.10/0 at the lowest dose of 50 呢/ml and K-562 by 27.7% at 100 ug/ml. WT4 could 
inhibit the viability of HL-60 by 83.8 % at 200 |Lig/ml but no effect on K-562. WT4-4 
could inhibit the proliferation of HL-60, K-562 and S-180 by 96.8%, 97% and 96.4% 
at 50 |ig/ml. The lowest significant inhibition on proliferation of HL-60, K-562 and 
S-180 were 0.78 ^ig/ml with 20.3% inhibition, 3.13 ^ig/ml with 10.5% inhibition and 
6.25 ^ig/ml with 34% inhibition. The I C 5 0 was 4 ^ig/ml, 6.5 ^ig/ml and 8 ^g/ml 
respectively. The inhibition on viability of the three cell lines was 100% at 50 ^ig/ml. 
The lowest effective dose in MCF-7 was 12.5 ^ig/ml and HepG2 was 25 ^ig/ml. The 
I C 5 0 of MCF-7 was 36 fig/ml and HepG2 was 24 ^ig/ml. WT4-4 did not show 
cytotoxicity on normal human liver cell line, L-02, up to the highest tested dose, 50 
叩/ml; and on normal monkey kidney cell line, Vero, up to 6.25 \iglm\. The I C 5 0 of 
WT4-4 A on proliferation of HL-60, K-562 and S-180 were 3 ^ig/ml, 3.4 |ag/ml and 
2 . 8 昭/ml respectively. The isolated crystal had antitumor activity with the I C 5 0 on 
HL-60 equal to 2.2 ^ig/ml. 
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WT4-4 also exhibited in vivo antitumor activity on Sarcoma 180 solid tumor. 
The significant doses ranging from the lowest concentration 0.8 mg/kg to 3.2 mg/kg 
in a dose-dependent manner with 33.72% and 62.79% respectively. 
In DNA agarose gel electrophoresis of WT4-4 treated HL-60, K-562 and S-180, 
no DNA laddering pattern was observed, indicating that the in vitro antitumor 
activity of WT4-4 was not accompanied with DNA fragmentation in these cell lines 
and so apoptosis was less likely to be induced by WT4-4. 
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